<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">FEBS J</journal-id><journal-id journal-id-type="publisher-id">febs</journal-id><journal-title-group><journal-title>The Febs Journal</journal-title></journal-title-group><issn pub-type="ppub">1742-464X</issn><issn pub-type="epub">1742-4658</issn><publisher><publisher-name>Blackwell Publishing Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3229708</article-id><article-id pub-id-type="doi">10.1111/j.1742-4658.2011.08186.x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Special Issue</subject></subj-group></article-categories><title-group><article-title>Understanding the complex mechanisms of &#x003b2;<sub>2</sub>-microglobulin amyloid assembly</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Eichner</surname><given-names>Timo</given-names></name><xref ref-type="aff" rid="au1">1</xref><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name><surname>Radford</surname><given-names>Sheena E</given-names></name><xref ref-type="aff" rid="au2">2</xref></contrib><aff id="au1"><label>1</label><institution>Department of Biochemistry, Brandeis University</institution><addr-line>Waltham, MA, USA</addr-line></aff><aff id="au2"><label>2</label><institution>Astbury Centre for Structural Molecular Biology and Institute of Molecular Cellular Biology, University of Leeds</institution><addr-line>UK</addr-line></aff></contrib-group><author-notes><corresp id="cor1">S. E. Radford, Astbury Centre for Structural Molecular Biology and Institute of Molecular Cellular Biology, University of Leeds, Leeds LS2 9JT, UK Fax: +44 113 343 7486 Tel: +44 113 343 3170 E-mail: <email>s.e.radford@leeds.ac.uk</email></corresp><corresp id="cor2">T. Eichner, Department of Biochemistry, Brandeis University, Waltham, MA 02454, USA Fax: +1 781 736 2316 Tel: +1 781 736 2326 E-mail: <email>teichner@brandeis.edu</email></corresp><fn><p>Re-use of this article is permitted in accordance with the Terms and Conditions set out at <ext-link ext-link-type="uri" xlink:href="http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms">http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms</ext-link></p></fn></author-notes><pub-date pub-type="ppub"><month>10</month><year>2011</year></pub-date><volume>278</volume><issue>20</issue><fpage>3868</fpage><lpage>3883</lpage><history><date date-type="received"><day>05</day><month>4</month><year>2011</year></date><date date-type="rev-recd"><day>11</day><month>5</month><year>2011</year></date><date date-type="accepted"><day>13</day><month>5</month><year>2011</year></date></history><permissions><copyright-statement>Journal compilation &#x000a9; 2011 Federation of European Biochemical Societies</copyright-statement><copyright-year>2011</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.</license-p></license></permissions><abstract><p>Several protein misfolding diseases are associated with the conversion of native proteins into ordered protein aggregates known as amyloid. Studies of amyloid assemblies have indicated that non-native proteins are responsible for initiating aggregation <italic>in vitro</italic> and <italic>in vivo</italic>. Despite the importance of these species for understanding amyloid disease, the structural and dynamic features of amyloidogenic intermediates and the molecular details of how they aggregate remain elusive. This review focuses on recent advances in developing a molecular description of the folding and aggregation mechanisms of the human amyloidogenic protein &#x003b2;<sub>2</sub>-microglobulin under physiologically relevant conditions. In particular, the structural and dynamic properties of the non-native folding intermediate I<sub>T</sub> and its role in the initiation of fibrillation and the development of dialysis-related amyloidosis are discussed.</p></abstract><kwd-group><kwd>amyloid</kwd><kwd>conformational conversion</kwd><kwd>dialysis-related amyloidosis</kwd><kwd>dynamics</kwd><kwd>NMR</kwd><kwd>prion</kwd></kwd-group></article-meta></front><body><sec><title>The role of &#x003b2;<sub>2</sub>-microglobulin in amyloid disease</title><p>&#x003b2;<sub>2</sub>-microglobulin (&#x003b2;<sub>2</sub>m) is the non-covalently bound light chain of the major histocompatibility complex class I (MHC I), wherein the protein plays an essential role in chaperoning assembly of the complex for antigen presentation (<xref ref-type="fig" rid="fig01">Fig. 1A</xref>) [<xref ref-type="bibr" rid="b1">1</xref>&#x02013;<xref ref-type="bibr" rid="b3">3</xref>]. Wild-type &#x003b2;<sub>2</sub>m contains 99 amino acids and has a classical &#x003b2;-sandwich fold comprising seven anti-parallel &#x003b2;-strands that is stabilized by its single inter-strand disulfide bridge between &#x003b2;-strands B and F (<xref ref-type="fig" rid="fig01">Fig. 1B</xref>) [<xref ref-type="bibr" rid="b4">4</xref>&#x02013;<xref ref-type="bibr" rid="b6">6</xref>]. The high resolution structures of monomeric native &#x003b2;<sub>2</sub>m from humans and several of its variants have been solved by solution NMR [<xref ref-type="bibr" rid="b7">7</xref>&#x02013;<xref ref-type="bibr" rid="b10">10</xref>] and X-ray crystallography [<xref ref-type="bibr" rid="b4">4</xref>,<xref ref-type="bibr" rid="b11">11</xref>&#x02013;<xref ref-type="bibr" rid="b16">16</xref>]. &#x003b2;<sub>2</sub>m contains five peptidyl&#x02013;prolyl bonds, one of which (His31-Pro32) adopts the thermodynamically unfavoured <italic>cis</italic>-isomer in the native state (<xref ref-type="fig" rid="fig01">Fig. 1B</xref>) [<xref ref-type="bibr" rid="b4">4</xref>,<xref ref-type="bibr" rid="b7">7</xref>,<xref ref-type="bibr" rid="b9">9</xref>]. Another interesting feature of monomeric native &#x003b2;<sub>2</sub>m is the conformational dynamics of the D-strand and the loop that connects the D- and E-strands (the DE-loop) (<xref ref-type="fig" rid="fig01">Fig. 1B</xref>). This region forms contacts with the MHC I heavy chain [<xref ref-type="bibr" rid="b17">17</xref>], but shows dynamics on a microsecond to millisecond timescale when a monomer in solution [<xref ref-type="bibr" rid="b7">7</xref>] and variability in different crystal structures (<xref ref-type="fig" rid="fig01">Fig. 1C,D</xref>) [<xref ref-type="bibr" rid="b13">13</xref>]. This rationalizes hydrogen&#x02013;deuterium exchange studies on monomeric native &#x003b2;<sub>2</sub>m showing that the DE-loop region exhibits enhanced backbone dynamics compared with the non-covalently MHC I bound state [<xref ref-type="bibr" rid="b18">18</xref>]. Notably, a link between the dynamic properties of monomeric native &#x003b2;<sub>2</sub>m, particularly in the D-strand and the DE-loop region, and its potential to assemble into amyloid fibrils has been proposed [<xref ref-type="bibr" rid="b7">7</xref>,<xref ref-type="bibr" rid="b10">10</xref>,<xref ref-type="bibr" rid="b11">11</xref>,<xref ref-type="bibr" rid="b18">18</xref>&#x02013;<xref ref-type="bibr" rid="b20">20</xref>].</p><fig id="fig01" position="float"><label>Fig. 1</label><caption><p>Monomeric &#x003b2;<sub>2</sub>m plays a key role in DRA. (A) Cartoon representation of human MHC I (PDB code 3MYJ [<xref ref-type="bibr" rid="b136">136</xref>]) showing the heavy chain (&#x003b1;1, &#x003b1;2, &#x003b1;3 in red) and the light chain (&#x003b2;<sub>2</sub>m in blue). Highlighted are the residues Pro5, Pro14, Pro32, Pro72 and Pro90 (in green sticks, spheres) and the disulfide bond between residues Cys25 and Cys80 (in yellow sticks). (B) Cartoon representation of the solution structure of monomeric native wild-type &#x003b2;<sub>2</sub>m (PDB code 2XKS [<xref ref-type="bibr" rid="b9">9</xref>]) showing &#x003b2;-strands A (6&#x02013;11), B (21&#x02013;28), C (36&#x02013;41), C&#x02032; (44&#x02013;45), D (50&#x02013;51), E (64&#x02013;70), F (79&#x02013;83) and G (91&#x02013;94). Highlighted are the residues Pro5, Pro14, Pro32, Pro72 and Pro90 (in sticks, spheres) and the disulfide bond between residues Cys25 and Cys80 (in sticks). N, N-terminus; C, C-terminus. (C) Structures displaying a &#x003b2;-bulge and an attached AB-loop: wild-type &#x003b2;<sub>2</sub>m (PDB code 1JNJ [<xref ref-type="bibr" rid="b7">7</xref>]) in red, H31Y (PDB code 1PY4 [<xref ref-type="bibr" rid="b15">15</xref>]) in green, W60G (PDB code 2VB5 [<xref ref-type="bibr" rid="b16">16</xref>]) in blue, H13F (PDB code 3CIQ [<xref ref-type="bibr" rid="b55">55</xref>]) in yellow and MHC I (PDB code 3MYJ [<xref ref-type="bibr" rid="b136">136</xref>]) in magenta. (D) Structures displaying a straight &#x003b2;-strand D: wild-type &#x003b2;<sub>2</sub>m (PDB code 1LDS [<xref ref-type="bibr" rid="b11">11</xref>]) in red, L39W/W60F/W95F (PDB code 2D4D [<xref ref-type="bibr" rid="b137">137</xref>]) in green, wild-type &#x003b2;<sub>2</sub>m (PDB code 2D4F [<xref ref-type="bibr" rid="b137">137</xref>]) in blue, wild-type &#x003b2;<sub>2</sub>m (PDB code 2YXF [<xref ref-type="bibr" rid="b12">12</xref>]) in yellow, W60G (PDB code 2Z9T [<xref ref-type="bibr" rid="b16">16</xref>]) in magenta, W60C (PDB code 3DHJ [<xref ref-type="bibr" rid="b14">14</xref>]) in cyan, D59P (PDB code 3DHM [<xref ref-type="bibr" rid="b14">14</xref>]) in orange, W60G (PDB code 3EKC [<xref ref-type="bibr" rid="b14">14</xref>]) in wheat, K58P/W60G (PDB code 3IB4 [<xref ref-type="bibr" rid="b121">121</xref>]) in black and P32A (PDB code 2F8O [<xref ref-type="bibr" rid="b58">58</xref>]) in grey.</p></caption><graphic xlink:href="febs0278-3868-f1"/></fig><p>Catabolism of &#x003b2;<sub>2</sub>m following its dissociation from the MHC I heavy chain occurs predominantly in the proximal tubules in the kidney [<xref ref-type="bibr" rid="b21">21</xref>,<xref ref-type="bibr" rid="b22">22</xref>]. As a consequence, the concentration of &#x003b2;<sub>2</sub>m circulating in the serum of patients suffering from renal dysfunction is enhanced up to 60-fold compared with healthy individuals. This causes the deposition of &#x003b2;<sub>2</sub>m as amyloid fibrils in osteoarticular tissues, leading to pathological bone destruction and the condition known as dialysis-related amyloidosis (DRA) (<xref ref-type="fig" rid="fig02">Fig. 2</xref>) [<xref ref-type="bibr" rid="b23">23</xref>]. However, a poor correlation between the &#x003b2;<sub>2</sub>m concentration in the serum and fibril load in osteoarticular tissues in long-term dialysis patients suggests that additional factors must be responsible for the initiation of &#x003b2;<sub>2</sub>m aggregation <italic>in vivo</italic> [<xref ref-type="bibr" rid="b24">24</xref>]. Consistent with these results, <italic>in vitro</italic> studies have shown that &#x003b2;<sub>2</sub>m is remarkably intransigent to assembly into amyloid fibrils at neutral pH, remaining predominantly monomeric for several months at pH 7.5, 37 &#x000b0;C, when incubated at protein concentrations more than 20-fold higher than those found in dialysis patients (&#x0223c; 3.2 &#x003bc;<sc>m</sc> [<xref ref-type="bibr" rid="b21">21</xref>]) [<xref ref-type="bibr" rid="b25">25</xref>,<xref ref-type="bibr" rid="b26">26</xref>]. As a consequence of these findings, factors have been sought that could facilitate protein aggregation of &#x003b2;<sub>2</sub>m <italic>in vivo</italic>, including the age of patients [<xref ref-type="bibr" rid="b27">27</xref>], the duration of kidney failure [<xref ref-type="bibr" rid="b28">28</xref>], the dialysis procedure itself [<xref ref-type="bibr" rid="b29">29</xref>&#x02013;<xref ref-type="bibr" rid="b31">31</xref>], post-translational modifications of full-length &#x003b2;<sub>2</sub>m [<xref ref-type="bibr" rid="b32">32</xref>&#x02013;<xref ref-type="bibr" rid="b40">40</xref>] and bimolecular collision between &#x003b2;<sub>2</sub>m and biological molecules abundant in osteoarticular tissues or encountered during dialysis [<xref ref-type="bibr" rid="b26">26</xref>,<xref ref-type="bibr" rid="b41">41</xref>&#x02013;<xref ref-type="bibr" rid="b51">51</xref>]. As a result, a multitude of factors have been shown to enhance the aggregation of &#x003b2;<sub>2</sub>m <italic>in vitro</italic> and are implicated <italic>in vivo</italic>, including Cu<sup>2+</sup> [<xref ref-type="bibr" rid="b47">47</xref>,<xref ref-type="bibr" rid="b52">52</xref>&#x02013;<xref ref-type="bibr" rid="b59">59</xref>], glycosaminoglycans [<xref ref-type="bibr" rid="b26">26</xref>,<xref ref-type="bibr" rid="b41">41</xref>,<xref ref-type="bibr" rid="b60">60</xref>], lysophosphatidic acid [<xref ref-type="bibr" rid="b49">49</xref>], non-esterified fatty acids [<xref ref-type="bibr" rid="b48">48</xref>,<xref ref-type="bibr" rid="b50">50</xref>] and collagen [<xref ref-type="bibr" rid="b41">41</xref>,<xref ref-type="bibr" rid="b42">42</xref>,<xref ref-type="bibr" rid="b61">61</xref>].</p><fig id="fig02" position="float"><label>Fig. 2</label><caption><p>Schematic of the key processes which result in the pathological symptoms experienced in DRA (reproduced, with permission, from [<xref ref-type="bibr" rid="b138">138</xref>]).</p></caption><graphic xlink:href="febs0278-3868-f2"/></fig><p>Amyloid formation of &#x003b2;<sub>2</sub>m under physiological pH conditions (around pH 7.0) commences from the fully folded native protein state [<xref ref-type="bibr" rid="b62">62</xref>]. Analysis of the thermodynamic stability of native wild-type &#x003b2;<sub>2</sub>m and an array of variants, however, showed no correlation between the thermodynamic stability of &#x003b2;<sub>2</sub>m and its potential to assemble into amyloid-like fibrils <italic>in vitro</italic> [<xref ref-type="bibr" rid="b62">62</xref>]. Instead, the formation of one or more non-native precursors that are accessible by dynamic fluctuations from the native protein is required before aggregation can occur [<xref ref-type="bibr" rid="b9">9</xref>,<xref ref-type="bibr" rid="b18">18</xref>&#x02013;<xref ref-type="bibr" rid="b20">20</xref>,<xref ref-type="bibr" rid="b63">63</xref>&#x02013;<xref ref-type="bibr" rid="b69">69</xref>]. Such fluctuations may expose aggregation-prone sequences normally sequestered in the native structure [<xref ref-type="bibr" rid="b70">70</xref>], consistent with local and/or more global unfolding events being a common feature in the aggregation mechanisms of globular proteins [<xref ref-type="bibr" rid="b58">58</xref>,<xref ref-type="bibr" rid="b67">67</xref>,<xref ref-type="bibr" rid="b71">71</xref>&#x02013;<xref ref-type="bibr" rid="b80">80</xref>].</p></sec><sec><title>Peptidyl&#x02013;prolyl isomerization initiates &#x003b2;<sub>2</sub>m amyloid assembly at physiological pH</title><p>In pioneering work, Chiti <italic>et al.</italic> [<xref ref-type="bibr" rid="b81">81</xref>] used a series of spectroscopic probes to show that wild-type &#x003b2;<sub>2</sub>m folds via two structurally distinct intermediates, known as I<sub>1</sub> and I<sub>2</sub>, <italic>en route</italic> to the globular native state. The first intermediate along the folding reaction coordinate, I<sub>1</sub>, is populated within 5 ms of dilution of the protein from denaturant. This species shows substantial elements of non-random structure and contains a disorganized hydrophobic core in which several hydrophobic residues remain exposed to solvent [<xref ref-type="bibr" rid="b81">81</xref>]. The second folding intermediate, I<sub>2</sub>, forms within milliseconds of the population of I<sub>1</sub> and displays native-like secondary structure and ordered packing of side chains within the hydrophobic core. Further folding of I<sub>2</sub> occurs on a timescale of seconds to minutes at 30 &#x000b0;C, suggesting substantial energetic barriers to the attainment of the globular native fold [<xref ref-type="bibr" rid="b62">62</xref>,<xref ref-type="bibr" rid="b81">81</xref>]. Although folding of wild-type &#x003b2;<sub>2</sub>m is a cooperative process as judged by equilibrium denaturation [<xref ref-type="bibr" rid="b81">81</xref>], I<sub>2</sub> nonetheless accumulates, reaching a population of about 14 &#x000b1; 8% at equilibrium at pH 7.4, 30 &#x000b0;C, as judged by capillary electrophoresis [<xref ref-type="bibr" rid="b82">82</xref>]. Importantly, the concentration of I<sub>2</sub> was found to correlate with the rate of elongation using seeds formed from <italic>ex vivo</italic> amyloid fibrils at pH 7.4, 30 &#x000b0;C, consistent with this native-like folding intermediate being directly (or indirectly via further conformational changes) capable of amyloid elongation [<xref ref-type="bibr" rid="b82">82</xref>]. A slow folding intermediate, reminiscent of I<sub>2</sub>, has also been described by others [<xref ref-type="bibr" rid="b34">34</xref>,<xref ref-type="bibr" rid="b83">83</xref>].</p><p>Building on the observations made by Chiti and colleagues [<xref ref-type="bibr" rid="b82">82</xref>], more detailed studies of the folding and unfolding mechanism of wild-type &#x003b2;<sub>2</sub>m, combined with mutagenesis of the sequence, demonstrated that the transition between the slow folding intermediate I<sub>2</sub> and the native fold is rate limited by <italic>trans</italic> to <italic>cis</italic> isomerization of the His31-Pro32 peptide bond, which led to the kinetically trapped intermediate being termed I<sub>T</sub> [<xref ref-type="bibr" rid="b67">67</xref>&#x02013;<xref ref-type="bibr" rid="b69">69</xref>]. Consistent with these findings, folding studies of a variant of &#x003b2;<sub>2</sub>m in which Pro32 is replaced with Val using manual mixing experiments at low temperature (2.8&#x02013;4.0 &#x000b0;C) monitored by CD and NMR revealed that the slow folding step is abolished, trapping &#x003b2;<sub>2</sub>m in a non-native species presumably with a <italic>trans</italic> His31-Val32 peptide bond [<xref ref-type="bibr" rid="b68">68</xref>]. Pro32 is highly conserved in &#x003b2;<sub>2</sub>m in different organisms [<xref ref-type="bibr" rid="b84">84</xref>] and <italic>trans</italic> to <italic>cis</italic> peptidyl&#x02013;prolyl isomerization at this site has been shown previously to be responsible for the slow refolding commonly found in other immunoglobulin domains [<xref ref-type="bibr" rid="b85">85</xref>&#x02013;<xref ref-type="bibr" rid="b91">91</xref>]. Interestingly, however, P32V &#x003b2;<sub>2</sub>m is not able to elongate amyloid fibrillar seeds <italic>in vitro</italic> or to nucleate fibril formation, suggesting that a <italic>trans</italic> His31-Xaa peptide bond is necessary, but not sufficient, to endow &#x003b2;<sub>2</sub>m with its amyloidogenic properties [<xref ref-type="bibr" rid="b68">68</xref>].</p><p>To gain a more detailed understanding of the kinetic folding mechanism of &#x003b2;<sub>2</sub>m and the role of different partially folded species in linking the folding and aggregation energy landscapes, Jahn and co-workers [<xref ref-type="bibr" rid="b67">67</xref>] analysed the folding and unfolding kinetics of &#x003b2;<sub>2</sub>m under an array of conditions, including analysis of the folding mechanism of the variant P32G. Using global analysis of the resulting kinetic data, the authors proposed a five-state model for the folding mechanism of wild-type &#x003b2;<sub>2</sub>m involving parallel folding pathways initiated from <italic>cis</italic> or <italic>trans</italic> His31-Pro32 in the unfolded state [<xref ref-type="bibr" rid="b67">67</xref>]. The five-state model has been challenged by Sakata and co-workers [<xref ref-type="bibr" rid="b69">69</xref>] who proposed that a simpler four-state model satisfies their obtained microscopic and macroscopic rates of &#x003b2;<sub>2</sub>m unfolding and refolding using chevron analysis. In particular, using their approach Sakata <italic>et al.</italic> were unable to detect spectroscopically the accumulation of the folding intermediate containing a native <italic>cis</italic>-His31-Pro32 peptide bond (I<sub>C</sub>), suggesting that this species is non-existent or populated to levels below the detection limit. Despite these differences, both folding models suggest that I<sub>T</sub> is low but significantly populated under physiological conditions at equilibrium, consistent with the poor ability of wild-type &#x003b2;<sub>2</sub>m to elongate fibrillar seeds at neutral pH <italic>in vitro</italic> [<xref ref-type="bibr" rid="b26">26</xref>,<xref ref-type="bibr" rid="b67">67</xref>]. Replacement of Pro32 with glycine (P32G) resulted in a simple three-state folding mechanism in which an intermediate, presumably with a <italic>trans</italic> His31-Gly32 peptide bond akin to I<sub>T</sub>, accumulates during folding, reaching an equilibrium concentration of approximately 30% [<xref ref-type="bibr" rid="b67">67</xref>]. Importantly, by titrating the population of I<sub>T</sub> populated at equilibrium for the wild-type protein and P32G by varying the solution conditions, Jahn <italic>et al.</italic> [<xref ref-type="bibr" rid="b67">67</xref>] showed that the population of I<sub>T</sub> correlates with the rate of fibril elongation <italic>in vitro</italic>, suggesting that I<sub>T</sub> is a key link between the folding and aggregation energy landscapes for this protein. This could occur directly by this species showing an ability to elongate amyloid seeds, or indirectly via further conformational excursions to other species accessible from this folding intermediate [<xref ref-type="bibr" rid="b9">9</xref>,<xref ref-type="bibr" rid="b20">20</xref>,<xref ref-type="bibr" rid="b66">66</xref>,<xref ref-type="bibr" rid="b67">67</xref>]. Interrogation of the conformational properties of P32G using NMR suggested large conformational changes involving residues in the BC- and FG-loops, the D-strand and the N-terminal region of the protein that presumably arise from the isomerization of Pro32 and subsequent partial unfolding of the protein [<xref ref-type="bibr" rid="b67">67</xref>]. These regions map precisely to the regions reported previously to be perturbed in the kinetic folding intermediate I<sub>T</sub>, suggesting a close structural relationship of the two species [<xref ref-type="bibr" rid="b67">67</xref>].</p><p>The intransigence of wild-type &#x003b2;<sub>2</sub>m to form amyloid fibrils when incubated for extended periods of time at neutral pH at concentrations substantially higher than those found <italic>in vivo</italic> [<xref ref-type="bibr" rid="b21">21</xref>,<xref ref-type="bibr" rid="b25">25</xref>,<xref ref-type="bibr" rid="b26">26</xref>] can be rationalized in light of the finding that the amyloidogenic precursor, I<sub>T</sub>, is both transiently sampled and maintained at low concentrations at equilibrium in the wild-type protein under ambient conditions [<xref ref-type="bibr" rid="b25">25</xref>,<xref ref-type="bibr" rid="b67">67</xref>,<xref ref-type="bibr" rid="b82">82</xref>]. In order to explore the thermodynamics and kinetics of amyloid assembly from &#x003b2;<sub>2</sub>m at physiological pH <italic>in vitro</italic>, therefore, a plethora of conditions have been used to increase the population of species akin (but not necessarily identical) to I<sub>T</sub> at equilibrium. These include the addition of Cu<sup>2+</sup> ions and urea [<xref ref-type="bibr" rid="b46">46</xref>,<xref ref-type="bibr" rid="b47">47</xref>,<xref ref-type="bibr" rid="b53">53</xref>,<xref ref-type="bibr" rid="b92">92</xref>], organic solvents [<xref ref-type="bibr" rid="b60">60</xref>,<xref ref-type="bibr" rid="b83">83</xref>], collagen [<xref ref-type="bibr" rid="b41">41</xref>,<xref ref-type="bibr" rid="b42">42</xref>], glycosaminoglycans or other biologically relevant factors [<xref ref-type="bibr" rid="b26">26</xref>,<xref ref-type="bibr" rid="b60">60</xref>,<xref ref-type="bibr" rid="b93">93</xref>], SDS or lysophospholipids [<xref ref-type="bibr" rid="b48">48</xref>&#x02013;<xref ref-type="bibr" rid="b51">51</xref>,<xref ref-type="bibr" rid="b94">94</xref>]. Changes in the physicochemical environment, including ultrasonication [<xref ref-type="bibr" rid="b95">95</xref>], heat treatment [<xref ref-type="bibr" rid="b96">96</xref>], high salt and stirring/agitation [<xref ref-type="bibr" rid="b97">97</xref>], have also been employed. These apparently very different conditions have in common the principle that they perturb the equilibrium position of the <italic>cis/trans</italic> His31-Pro32 peptide bond and hence enhance the amyloidogenic potential of the wild-type protein [<xref ref-type="bibr" rid="b25">25</xref>]. Mutations in the N- and/or C-terminal regions of the sequence have also been shown to enhance amyloid formation of &#x003b2;<sub>2</sub>m at physiological pH [<xref ref-type="bibr" rid="b8">8</xref>,<xref ref-type="bibr" rid="b9">9</xref>,<xref ref-type="bibr" rid="b25">25</xref>,<xref ref-type="bibr" rid="b26">26</xref>,<xref ref-type="bibr" rid="b32">32</xref>,<xref ref-type="bibr" rid="b98">98</xref>,<xref ref-type="bibr" rid="b99">99</xref>], whilst other mutations that focus on the DE-loop region demonstrated variable effects on the thermodynamic stability of the protein depending on the amount of strain introduced [<xref ref-type="bibr" rid="b14">14</xref>,<xref ref-type="bibr" rid="b16">16</xref>,<xref ref-type="bibr" rid="b20">20</xref>,<xref ref-type="bibr" rid="b100">100</xref>,<xref ref-type="bibr" rid="b101">101</xref>]. DE-loop mutations such as D59P that introduce loop strain show a decreased folding free energy compared with the wild-type protein and an enhanced potential to aggregate, whereas a release of loop strain such as in W60G leads to super-stable variants which have reduced amyloidogenic features [<xref ref-type="bibr" rid="b13">13</xref>,<xref ref-type="bibr" rid="b14">14</xref>,<xref ref-type="bibr" rid="b16">16</xref>]. However, DE-loop cleavage variants such as &#x00394;K58 or cK58 (which contain a specific cleavage at Lys58 with or without removal of Lys58, respectively) have been demonstrated to be highly aggregation-prone [<xref ref-type="bibr" rid="b34">34</xref>,<xref ref-type="bibr" rid="b102">102</xref>&#x02013;<xref ref-type="bibr" rid="b104">104</xref>]. Together these studies are indicative of a fragile and delicate amino acid network required for the stabilization of the <italic>cis</italic> isomer at His31-Pro32 that is required both for binding to the MHC I heavy chain [<xref ref-type="bibr" rid="b16">16</xref>] and to maintain a soluble native structure for the monomeric protein.</p></sec><sec><title>&#x003b2;<sub>2</sub>m assembly mechanisms at atomic resolution</title><p>Clinical studies have shown that dialysis patients treated with Cu<sup>2+</sup>-free filter membranes have a &#x0003e; 50% reduced incidence of DRA compared with patients who were exposed to traditional Cu<sup>2+</sup>-containing dialysis membranes [<xref ref-type="bibr" rid="b27">27</xref>,<xref ref-type="bibr" rid="b105">105</xref>]. These studies suggest that Cu<sup>2+</sup> ions may play a role in initiating or enhancing aggregation of wild-type &#x003b2;<sub>2</sub>m in DRA. Indeed, Cu<sup>2+</sup> has been shown to bind to native human &#x003b2;<sub>2</sub>m with moderate affinity (<italic>K</italic><sub>app</sub> = 2.7 &#x003bc;<sc>m</sc>) and specificity (Cu<sup>2+</sup> &#x0003e; Zn<sup>2+</sup> &#x0003e;&#x0003e; Ni<sup>2+</sup>) [<xref ref-type="bibr" rid="b46">46</xref>,<xref ref-type="bibr" rid="b106">106</xref>]. Binding involves coordination to the imidizole ring of His31 [<xref ref-type="bibr" rid="b7">7</xref>,<xref ref-type="bibr" rid="b107">107</xref>]. Non-native states of wild-type &#x003b2;<sub>2</sub>m also bind Cu<sup>2+</sup> ions; in this case the three other histidines in the sequence (His13, His51, His84) coordinate Cu<sup>2+</sup> with a <italic>K</italic><sub>app</sub> &#x0223c; 41 &#x003bc;<sc>m</sc> [<xref ref-type="bibr" rid="b107">107</xref>]. As a consequence, binding of Cu<sup>2+</sup> ions increases the concentration of non-native (so-called &#x02018;activated&#x02019;) forms of monomeric &#x003b2;<sub>2</sub>m, named by Miranker and co-authors as M*, which triggers the formation of dimeric, tetrameric and hexameric species (&#x0003c; 1 h) believed to be on-pathway to amyloid-like fibrils [<xref ref-type="bibr" rid="b47">47</xref>,<xref ref-type="bibr" rid="b106">106</xref>]. Cu<sup>2+</sup> binding is required for the conformational changes leading to the formation of M* and to the generation of early oligomeric species. However, once these oligomeric species and subsequent fibrillar aggregates are formed, Cu<sup>2+</sup> is not essential for their stability [<xref ref-type="bibr" rid="b52">52</xref>,<xref ref-type="bibr" rid="b54">54</xref>,<xref ref-type="bibr" rid="b56">56</xref>,<xref ref-type="bibr" rid="b57">57</xref>,<xref ref-type="bibr" rid="b108">108</xref>]. By creating two variants, P32A and H13F, Miranker and colleagues [<xref ref-type="bibr" rid="b55">55</xref>,<xref ref-type="bibr" rid="b58">58</xref>] were able to crystallize dimeric and hexameric forms of &#x003b2;<sub>2</sub>m (the latter after Cu<sup>2+</sup>-induced oligomerization). These studies revealed that dimeric P32A and hexameric H13F contain a <italic>trans</italic> His31-Ala32 and a <italic>trans</italic> His31-Pro32 peptide bond, respectively. Each oligomer is composed of monomers that retain a native-like fold, yet display significant alterations in the organization of aromatic side chains within the hydrophobic core, most notably Phe30, Phe62 and Trp60 (<xref ref-type="fig" rid="fig03">Fig. 3A,B</xref>, in blue), which the authors speculate could be important determinants of amyloid assembly [<xref ref-type="bibr" rid="b53">53</xref>,<xref ref-type="bibr" rid="b55">55</xref>,<xref ref-type="bibr" rid="b58">58</xref>]. How these static structures relate to the transient intermediates formed during folding or populated during aggregation, however, remain unclear. Importantly in this regard, P32A and H13F lack an enhanced ability to assemble into amyloid fibrils compared with wild-type &#x003b2;<sub>2</sub>m [<xref ref-type="bibr" rid="b55">55</xref>,<xref ref-type="bibr" rid="b58">58</xref>], reminiscent of the behaviour of P32V [<xref ref-type="bibr" rid="b68">68</xref>,<xref ref-type="bibr" rid="b69">69</xref>]. Despite containing a <italic>trans</italic> His31-Xaa32 peptide bond, these species lack structural and/or dynamical properties critical for amyloid formation.</p><fig id="fig03" position="float"><label>Fig. 3</label><caption><p>Molecular description of the I<sub>T</sub> state using X-ray crystallography and high resolution solution NMR. (A) The ribbon overlay shows one monomer of the hexameric crystal structure of H13F (PDB code 3CIQ [<xref ref-type="bibr" rid="b55">55</xref>], in blue) and the lowest energy structure of &#x00394;N6 (PDB code 2XKU) [<xref ref-type="bibr" rid="b9">9</xref>] (in red). The residues Phe30, Pro32, Trp60, Phe62 and His84 are highlighted in sticks. The dashed green box indicates a zoom-in for this region shown in (B). (C) <sup>1</sup>H&#x02013;<sup>15</sup>N HSQC of wild-type &#x003b2;<sub>2</sub>m in 18% (v/v) TFE at pH 6.6 and 33 &#x000b0;C (reproduced, with permission, from [<xref ref-type="bibr" rid="b20">20</xref>]). Green circles are assigned resonances for I<sub>T</sub>, while blue circles indicate the TFE induced, structurally disordered D state that is thought to be precursor for fibril elongation under these conditions. (D) <sup>1</sup>H&#x02013;<sup>15</sup>N HSQC overlay of wild-type &#x003b2;<sub>2</sub>m (black) and &#x00394;N6 (red) recorded in 25 m<sc>m</sc> sodium phosphate buffer pH 7.5, 25 &#x000b0;C. (E) <sup>1</sup>H&#x02013;<sup>15</sup>N SOFAST HMQC overlay of &#x00394;N6 (red) and the kinetic intermediate I<sub>T</sub> (green) recorded approximately 2 min after refolding was initiated (25 m<sc>m</sc> sodium phosphate buffer pH 7.5, 0.8 <sc>m</sc> residual urea, 25 &#x000b0;C). Reproduced with permission from [<xref ref-type="bibr" rid="b9">9</xref>].</p></caption><graphic xlink:href="febs0278-3868-f3"/></fig><p>Increased conformational dynamics has emerged as a common feature of the assembly of &#x003b2;<sub>2</sub>m monomers into amyloid fibrils at neutral pH from a wealth of studies under varied solution conditions [<xref ref-type="bibr" rid="b9">9</xref>,<xref ref-type="bibr" rid="b10">10</xref>,<xref ref-type="bibr" rid="b18">18</xref>&#x02013;<xref ref-type="bibr" rid="b20">20</xref>,<xref ref-type="bibr" rid="b32">32</xref>,<xref ref-type="bibr" rid="b65">65</xref>&#x02013;<xref ref-type="bibr" rid="b67">67</xref>,<xref ref-type="bibr" rid="b92">92</xref>,<xref ref-type="bibr" rid="b103">103</xref>,<xref ref-type="bibr" rid="b109">109</xref>], akin to the findings on other proteins that also assemble into amyloid fibrils commencing from folded monomeric states [<xref ref-type="bibr" rid="b64">64</xref>,<xref ref-type="bibr" rid="b71">71</xref>,<xref ref-type="bibr" rid="b73">73</xref>,<xref ref-type="bibr" rid="b76">76</xref>,<xref ref-type="bibr" rid="b77">77</xref>,<xref ref-type="bibr" rid="b80">80</xref>,<xref ref-type="bibr" rid="b110">110</xref>&#x02013;<xref ref-type="bibr" rid="b116">116</xref>]. Accordingly, &#x00394;N6 (in which &#x003b2;<sub>2</sub>m is cleaved at Lys6) [<xref ref-type="bibr" rid="b32">32</xref>], cK58 and &#x00394;K58 [<xref ref-type="bibr" rid="b34">34</xref>,<xref ref-type="bibr" rid="b102">102</xref>,<xref ref-type="bibr" rid="b103">103</xref>,<xref ref-type="bibr" rid="b117">117</xref>,<xref ref-type="bibr" rid="b118">118</xref>] and wild-type &#x003b2;<sub>2</sub>m in the presence of SDS/2,2,2-trifluoroethanol (TFE)/other additives [<xref ref-type="bibr" rid="b20">20</xref>,<xref ref-type="bibr" rid="b41">41</xref>,<xref ref-type="bibr" rid="b42">42</xref>,<xref ref-type="bibr" rid="b50">50</xref>,<xref ref-type="bibr" rid="b51">51</xref>,<xref ref-type="bibr" rid="b66">66</xref>,<xref ref-type="bibr" rid="b119">119</xref>] all exhibit decreased solubility, increased local and global unfolding events and enhanced amyloidogenicity at pH values close to physiological. Of particular interest is the variant &#x00394;N6, since this species is found as a significant component (&#x0223c; 26%) in <italic>ex vivo</italic> amyloid deposits and exhibits an increased affinity for collagen compared with the wild-type protein, suggesting a role for this protein in the development of DRA [<xref ref-type="bibr" rid="b61">61</xref>,<xref ref-type="bibr" rid="b120">120</xref>]. Pioneering work by Esposito and colleagues showed that &#x00394;N6 experiences a global decrease in conformational stability compared with wild-type &#x003b2;<sub>2</sub>m and, using molecular dynamics simulations, the authors proposed that the D-strand facilitates intermolecular interactions to form oligomeric assemblies prior to the development of long straight amyloid fibrils at pH 6.5, 37 &#x000b0;C [<xref ref-type="bibr" rid="b32">32</xref>]. Similarly, the variants cK58 and &#x00394;K58 were found to be highly aggregation-prone, presumably due to enhanced conformational dynamics, especially for strand D, and a concomitant increase in concentration of the amyloidogenic folding intermediates at equilibrium [<xref ref-type="bibr" rid="b34">34</xref>,<xref ref-type="bibr" rid="b103">103</xref>]. In contrast, the mutation W60G which also lies in the DE-loop diminishes the potential of this variant to extend fibrillar seeds of the human wild-type protein at pH 7.4 in the presence of 20% (v/v) TFE [<xref ref-type="bibr" rid="b16">16</xref>], consistent with the dynamics within this region of the protein playing a crucial role in &#x003b2;<sub>2</sub>m assembly at neutral pH [<xref ref-type="bibr" rid="b13">13</xref>,<xref ref-type="bibr" rid="b14">14</xref>,<xref ref-type="bibr" rid="b19">19</xref>,<xref ref-type="bibr" rid="b20">20</xref>,<xref ref-type="bibr" rid="b66">66</xref>,<xref ref-type="bibr" rid="b121">121</xref>]. These studies therefore reinforce the importance of interrogating the conformational dynamics of &#x003b2;<sub>2</sub>m and its truncation variants in more detail in order to understand the aggregation properties of this species and, more generally, how other non-native species that retain a globular fold aggregate <italic>in vitro</italic> and <italic>in vivo</italic> [<xref ref-type="bibr" rid="b116">116</xref>].</p><p>Major breakthroughs in understanding the properties that endow non-native states of &#x003b2;<sub>2</sub>m with their amyloidogenic properties have arisen from NMR studies of wild-type &#x003b2;<sub>2</sub>m and several variants of the protein by exploiting the capabilities of modern NMR methods for rapid and sensitive data acquisition [<xref ref-type="bibr" rid="b7">7</xref>,<xref ref-type="bibr" rid="b9">9</xref>,<xref ref-type="bibr" rid="b11">11</xref>,<xref ref-type="bibr" rid="b20">20</xref>,<xref ref-type="bibr" rid="b32">32</xref>,<xref ref-type="bibr" rid="b55">55</xref>,<xref ref-type="bibr" rid="b58">58</xref>,<xref ref-type="bibr" rid="b66">66</xref>&#x02013;<xref ref-type="bibr" rid="b68">68</xref>,<xref ref-type="bibr" rid="b103">103</xref>,<xref ref-type="bibr" rid="b109">109</xref>]. Accordingly, recent studies of the folding kinetics of wild-type &#x003b2;<sub>2</sub>m using real-time NMR combined with amino acid selective labelling of Phe, Val and Leu provided the first glimpses of the amyloid precursor of &#x003b2;<sub>2</sub>m under conditions close to physiological [<xref ref-type="bibr" rid="b109">109</xref>]. However, extensive peak broadening caused by conformational dynamics on a microsecond to millisecond timescale ruled out detailed assignment and structure elucidation of I<sub>T</sub>. Following on from this work, studies of the folding kinetics of wild-type &#x003b2;<sub>2</sub>m in different concentrations of TFE using real-time NMR revealed that the native protein is generated with double exponential kinetics from I<sub>T</sub> for all resonances studied, indicative of an energy landscape that is more complex than the single barrier suspected hitherto [<xref ref-type="bibr" rid="b66">66</xref>,<xref ref-type="bibr" rid="b67">67</xref>,<xref ref-type="bibr" rid="b69">69</xref>]. By contrast with the behaviour of the wild-type protein, W60G folds to the native state from I<sub>T</sub> with mono-exponential kinetics, indicative of a more simple folding energy landscape for this less amyloidogenic variant [<xref ref-type="bibr" rid="b66">66</xref>]. Based on these results, the authors propose that a species that is more disordered than I<sub>T</sub> (named a &#x02018;native-unlike&#x02019; or D state), formed maximally in 20% (v/v) TFE, is responsible for elongating wild-type &#x003b2;<sub>2</sub>m seeds [<xref ref-type="bibr" rid="b20">20</xref>]. The wild-type protein under those conditions has also been simulated using molecular dynamics [<xref ref-type="bibr" rid="b122">122</xref>]. Exploiting the sensitivity of &#x003b2;<sub>2</sub>m conformations to the concentration of TFE, the authors were able to find conditions wherein I<sub>T</sub> is maximally populated from W60G, reaching 30&#x02013;40% population in 18% (v/v) TFE (at pH 6.6, 33 &#x000b0;C), and were able to assign 63 backbone amide resonances (out of 93 amide bonds) unambiguously for this species (BMRB code 16587) (<xref ref-type="fig" rid="fig03">Fig. 3C</xref>) [<xref ref-type="bibr" rid="b20">20</xref>]. Incomplete assignment of the I<sub>T</sub> state in W60G and considerable peak overlap by native state resonances, however, hampered the assignment of the backbone conformation of the peptidyl&#x02013;prolyl bond at Pro32 and a more detailed structural and dynamic characterization of this intermediate [<xref ref-type="bibr" rid="b20">20</xref>].</p><p>Most recently, the difficulties in determining the conformational properties of I<sub>T</sub> have been overcome by using the &#x003b2;<sub>2</sub>m truncation variant &#x00394;N6 as a structural mimic of this species (<xref ref-type="fig" rid="fig03">Fig. 3A,B</xref>, in red) [<xref ref-type="bibr" rid="b9">9</xref>,<xref ref-type="bibr" rid="b25">25</xref>]. High resolution NMR studies directly comparing the <sup>1</sup>H&#x02013;<sup>15</sup>N HSQC spectra of &#x00394;N6 and I<sub>T</sub> revealed that the major species populated by &#x00394;N6 in solution at pH 7.5, 25 &#x000b0;C, closely resembles the transient folding intermediate I<sub>T</sub> (<xref ref-type="fig" rid="fig03">Fig. 3D,E</xref>). Using &#x00394;N6 as a structural model for I<sub>T</sub>, full resonance assignment and structural elucidation were possible, revealing the structural and dynamical properties of this non-native conformer of &#x003b2;<sub>2</sub>m. The results showed that under the conditions employed &#x00394;N6 retains a native fold but undergoes a major re-packing of several side chains within the hydrophobic core to accommodate the non-native <italic>trans</italic>-conformation of the His31-Pro32 peptide bond (<xref ref-type="fig" rid="fig03">Fig. 3A,B</xref>, in red). Intriguingly, the side chains involved map predominantly to the same residues that undergo structural reorganization in the presence of Cu<sup>2+</sup> ions, although the precise packing of residues remains different in many cases (<xref ref-type="fig" rid="fig03">Fig. 3A,B</xref>) [<xref ref-type="bibr" rid="b9">9</xref>,<xref ref-type="bibr" rid="b55">55</xref>,<xref ref-type="bibr" rid="b58">58</xref>]. Despite adopting a thermodynamically stable [<xref ref-type="bibr" rid="b9">9</xref>,<xref ref-type="bibr" rid="b25">25</xref>] native-like topology, &#x00394;N6 is a highly dynamic entity, possessing only limited protection from hydrogen exchange together with pH- and concentration-dependent sensitivity of its backbone dynamics on a microsecond to millisecond timescale. These data suggest that increased conformational dynamics of &#x00394;N6 correlate with an increase in its amyloidogenic properties presumably by enabling the formation of one or more rarely populated conformers that have an enhanced potential to assemble into amyloid fibrils [<xref ref-type="bibr" rid="b9">9</xref>,<xref ref-type="bibr" rid="b32">32</xref>,<xref ref-type="bibr" rid="b123">123</xref>]. One of the key events in this amyloid switch is protonation of His84, which experiences a large p<italic>K</italic><sub>a</sub> shift from &#x0223c; 4 to &#x0223c; 7 upon peptidyl&#x02013;prolyl isomerization of the His31-Pro32 peptide bond (<xref ref-type="fig" rid="fig04">Fig. 4A</xref>) [<xref ref-type="bibr" rid="b9">9</xref>]. The involvement of His84 in the initiation of &#x003b2;<sub>2</sub>m amyloid fibril formation has been proposed previously using computational methods [<xref ref-type="bibr" rid="b61">61</xref>]. Oligomeric structures which become available after peptidyl&#x02013;prolyl isomerization and exploration of conformational space upon His84 protonation have been proposed previously in association with Cu<sup>2+</sup> binding [<xref ref-type="bibr" rid="b55">55</xref>,<xref ref-type="bibr" rid="b58">58</xref>], in the presence of dithiothreitol [<xref ref-type="bibr" rid="b124">124</xref>] or by the binding of nanobodies [<xref ref-type="bibr" rid="b125">125</xref>]. Interestingly, the last two conditions result in the formation of oligomers that are domain swapped, as proposed hitherto for &#x003b2;<sub>2</sub>m assembly under native conditions using computational methods [<xref ref-type="bibr" rid="b126">126</xref>] or Cu<sup>2+</sup> treatment [<xref ref-type="bibr" rid="b106">106</xref>]. Whether domain swapping occurs in DRA, however, remains to be elucidated. Another open question is the structural and dynamic similarities and differences between <italic>trans</italic> intermediates formed under different conditions (such as alterations of pH and temperature, Cu<sup>2+</sup> treatment, mutagenesis (&#x00394;N6) or addition of organic solvent (TFE)) and how these map to the structure determined for &#x00394;N6 at neutral pH [<xref ref-type="bibr" rid="b9">9</xref>] or that of the more ephemeral amyloid precursors that form from this protein or from the folding intermediate I<sub>T</sub>. Nonetheless, these data are suggestive of a mechanism of assembly under different solution conditions that contains many features in common.</p><fig id="fig04" position="float"><label>Fig. 4</label><caption><p>Prion-like conversion during amyloid formation. (A) Summary showing the structures of wild-type &#x003b2;<sub>2</sub>m (PDB code 2XKS) and a model of I<sub>T</sub>. Above, keys for these conformational states. Native wild-type &#x003b2;<sub>2</sub>m (leftmost), shown above as a circle with <italic>cis</italic> His31-Pro32 (green &#x00393;), <italic>trans</italic> His13-Pro14 (blue &#x00393;), His84 (orange circle) and the N-terminal region (residues 1&#x02013;6, blue arrow). Backbone atoms of residues which establish strong hydrogen bonding between &#x003b2;-strands A and B in the native state are shown in sticks. Upon dissociation of the N-terminal region, the His31-Pro32 peptide bond is free to relax into the <italic>trans</italic>-conformation, causing further conformational changes that lead to the formation of the non-native I<sub>T</sub> conformer (shown as a circle above a model of its structure). Protonation of His84 under mildly acidic conditions (shown in red ball and stick and as an orange square in the model above), which lies adjacent to Pro32, enhances the amyloid potential of I<sub>T</sub> further. Oligomerization of these aggregation-prone species then leads to the formation of &#x003b2;<sub>2</sub>m amyloid fibrils. Assuming that the fibrils formed at neutral pH are structurally similar to those formed at acidic pH, as suggested by FTIR [<xref ref-type="bibr" rid="b135">135</xref>] and solid state NMR [<xref ref-type="bibr" rid="b133">133</xref>,<xref ref-type="bibr" rid="b134">134</xref>], large conformational changes are required in order to transform the anti-parallel &#x003b2;-sheet arrangement of &#x00394;N6 into the parallel in-register arrangement of &#x003b2;-strands characteristic of &#x003b2;<sub>2</sub>m amyloid fibrils, as reported recently [<xref ref-type="bibr" rid="b132">132</xref>] (reproduced, with permission, from [<xref ref-type="bibr" rid="b9">9</xref>]). (B) Summary showing the consequences of &#x003b2;<sub>2</sub>m cleavage of the N-terminal hexapeptide that generates &#x00394;N6 as a persistent I<sub>T</sub> state (PDB code 2XKU). Once formed &#x00394;N6 is able to nucleate and elongate its own fibrils and also to cross-seed elongation of its fibrillar seeds with the wild-type protein, leading to the development of long straight amyloid-like fibrils (the image of the fibrils was redrawn from the cryo-EM structure of &#x003b2;<sub>2</sub>m amyloid fibrils from [<xref ref-type="bibr" rid="b139">139</xref>]). Furthermore, &#x00394;N6 can transform the innocuous native state of &#x003b2;<sub>2</sub>m via bimolecular collision. The formation of catalytic amounts of &#x00394;N6 thus has been proposed to be a cataclysmic event during the development of DRA.</p></caption><graphic xlink:href="febs0278-3868-f4"/></fig></sec><sec><title>Prion-like conversion during &#x003b2;<sub>2</sub>m amyloid assembly</title><p>Despite the finding that &#x00394;N6 comprises &#x0223c; 26% of &#x003b2;<sub>2</sub>m in amyloid deposits in patients with DRA, this species is not found in the serum of people with renal dysfunction [<xref ref-type="bibr" rid="b127">127</xref>]. As a consequence of these findings, formation of &#x00394;N6 has been proposed to occur as a post-assembly event [<xref ref-type="bibr" rid="b123">123</xref>]. Most recently, however, it has been demonstrated that &#x00394;N6 is not only able to nucleate fibrillogenesis efficiently <italic>in vitro</italic> at physiological pH as discussed above (<xref ref-type="fig" rid="fig04">Fig. 4B</xref>) [<xref ref-type="bibr" rid="b9">9</xref>,<xref ref-type="bibr" rid="b25">25</xref>,<xref ref-type="bibr" rid="b26">26</xref>] but, as a persistent <italic>trans</italic>-Pro32 state, &#x00394;N6 is also able to convert wild-type &#x003b2;<sub>2</sub>m into an aggregation-competent conformer by bimolecular collision between the two monomers (<xref ref-type="fig" rid="fig04">Fig. 4B</xref>) [<xref ref-type="bibr" rid="b9">9</xref>]. Accordingly, only catalytic amounts (1%) of &#x00394;N6 are sufficient to convert significant quantities of the wild-type protein into amyloid fibrils (<xref ref-type="fig" rid="fig04">Fig. 4B</xref>). Detailed interrogation of bimolecular collision between native wild-type &#x003b2;<sub>2</sub>m and &#x00394;N6 using NMR revealed the molecular mechanism by which this prion-like templating might occur [<xref ref-type="bibr" rid="b9">9</xref>]. First, &#x00394;N6 binds specifically, but transiently, to native wild-type &#x003b2;<sub>2</sub>m, possibly involving residues of &#x003b2;-strands A, B and D and the DE-loop. This interaction changes the native configuration of Pro14 within the AB-loop which is highly dynamic as indicated by molecular dynamics simulations [<xref ref-type="bibr" rid="b63">63</xref>,<xref ref-type="bibr" rid="b122">122</xref>] and X-ray crystallography (<xref ref-type="fig" rid="fig01">Fig. 1C,D</xref>). Pro14 dynamics have been shown hitherto to be responsible for an alternative &#x003b2;<sub>2</sub>m conformation in which the hydrogen bonding between &#x003b2;-strands A and B is severely impaired [<xref ref-type="bibr" rid="b15">15</xref>]. Inter-strand hydrogen bonding between those two strands, together with the correct attachment of the N-terminal hexapeptide, has been demonstrated to be crucial in maintaining a low concentration of I<sub>T</sub> at equilibrium [<xref ref-type="bibr" rid="b25">25</xref>]. Binding of &#x00394;N6 to wild-type &#x003b2;<sub>2</sub>m, therefore, leads to the disruption of important interactions between the N-terminal hexapeptide and the BC-loop, leading to accelerated relaxation kinetics towards the amyloidogenic <italic>trans</italic> His31-Pro32 isomeric state. The truncation variant &#x00394;N6 is thus capable of driving the innocuous native wild-type protein into aggregation-competent entities, reminiscent of the action of prions. Such an observation rationalizes the lack of circulating &#x00394;N6 in the serum and, given the natural affinity of this species for collagen (which is enhanced relative to wild-type &#x003b2;<sub>2</sub>m [<xref ref-type="bibr" rid="b61">61</xref>]), explains why assembly of fibrils occurs most readily in collagen-rich joints. Rather than being an innocuous post-assembly event, therefore, proteolytic cleavage of &#x003b2;<sub>2</sub>m to create one or more species truncated at the N-terminus could be a key initiating event in DRA, enabling the formation of a species that is not only able to assemble <italic>de novo</italic> into amyloid fibrils but can enhance fibrillogenesis of wild-type &#x003b2;<sub>2</sub>m. The latter is accomplished by initiating the ability of the wild-type protein to nucleate its own assembly, or by cross-seeding fibril elongation of &#x00394;N6 seeds with wild-type monomers (<xref ref-type="fig" rid="fig04">Fig. 4</xref>). Identifying the proteases responsible for the production of &#x00394;N6 or using the high resolution structure of &#x00394;N6 as a target for the design of small molecules able to intervene in assembly may provide new approaches for therapeutic intervention in DRA.</p></sec><sec><title>Outlook: towards a complete molecular description of &#x003b2;<sub>2</sub>m amyloidosis</title><p>In this review we have highlighted the importance of conformational dynamics for the initiation and development of &#x003b2;<sub>2</sub>m amyloid formation commencing from the natively folded state. Detailed analysis of the folding, stability and amyloidogenicity of a number of different proteins has revealed that a polypeptide chain can adopt a diversity of structures within a multidimensional energy landscape, the thermodynamics and kinetics of which are dependent on the protein sequence and solution conditions employed [<xref ref-type="bibr" rid="b128">128</xref>]. One key feature that appears to identify amyloidogenic proteins from their non-amyloidogenic counterparts is a lack of structural cooperativity that is revealed by enhanced conformational dynamics on a microsecond to millisecond timescale, often portrayed by increased rates of proteolysis, hydrogen exchange and <italic>R</italic><sub>2</sub> NMR relaxation rates [<xref ref-type="bibr" rid="b115">115</xref>]. Such motions may expose sequences with high amyloid potential that are usually hidden within the native structure [<xref ref-type="bibr" rid="b70">70</xref>] or may endow surface properties that enable new protein&#x02013;protein interactions to form. Studies of &#x003b2;<sub>2</sub>m have contributed substantially to this view, resulting most recently in a high resolution structure for the amyloid-initiating folding intermediate I<sub>T</sub> and the beginnings of a molecular understanding of why increased conformational dynamics make this species highly aggregation-prone [<xref ref-type="bibr" rid="b9">9</xref>]. Rather than an innocuous post-assembly event, the work suggests proteolytic cleavage as a cataclysmic event that releases a species that is not only able to spawn further aggregation-prone species but is also able to convert the wild-type protein into an amyloidogenic state via conformational conversion akin to the activity famously associated with prions [<xref ref-type="bibr" rid="b129">129</xref>&#x02013;<xref ref-type="bibr" rid="b131">131</xref>]. Finally, many studies of &#x003b2;<sub>2</sub>m amyloid assembly under a wide range of conditions, some close to physiological and others utilizing metal ions or solvent additives to drive fibrillogenesis at neutral pH, have together revealed common principles of &#x003b2;<sub>2</sub>m self-assembly which are related by the formation of non-native species initiated by a <italic>cis</italic> to <italic>trans</italic> His31-Pro32 switch despite the wide range of conditions employed. Further work is now needed to define the origins of molecular recognition between monomers and oligomers that form as assembly progresses into amyloid fibrils at neutral pH and to define the extent of further conformational changes required to form the cross-&#x003b2; structure of amyloid [<xref ref-type="bibr" rid="b132">132</xref>&#x02013;<xref ref-type="bibr" rid="b135">135</xref>]. This will entail greater structural knowledge about the multitude of protein states populated on the folding and aggregation energy landscapes and how these species are formed and interconnected.</p></sec></body><back><ack><p>We thank David Brockwell and members of the Radford and Homans research groups for helpful discussions. We acknowledge, with thanks, the Wellcome Trust (062164 and GR075675MA) and the University of Leeds for funding.</p></ack><ref-list><title>References</title><ref id="b1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zijlstra</surname><given-names>M</given-names></name><name><surname>Bix</surname><given-names>M</given-names></name><name><surname>Simister</surname><given-names>NE</given-names></name><name><surname>Loring</surname><given-names>JM</given-names></name><name><surname>Raulet</surname><given-names>DH</given-names></name><name><surname>Jaenisch</surname><given-names>R</given-names></name></person-group><article-title>Beta2-microglobulin deficient mice lack CD4-8+ cytolytic T cells</article-title><source>Nature</source><year>1990</year><volume>344</volume><fpage>742</fpage><lpage>746</lpage><pub-id pub-id-type="pmid">2139497</pub-id></element-citation></ref><ref id="b2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>EA</given-names></name><name><surname>Hammond</surname><given-names>C</given-names></name><name><surname>Cresswell</surname><given-names>P</given-names></name></person-group><article-title>Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome</article-title><source>Proc Natl Acad Sci USA</source><year>1997</year><volume>94</volume><fpage>1896</fpage><lpage>1901</lpage><pub-id pub-id-type="pmid">9050876</pub-id></element-citation></ref><ref id="b3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paulsson</surname><given-names>KM</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Anderson</surname><given-names>PO</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Pettersson</surname><given-names>RF</given-names></name><name><surname>Li</surname><given-names>S</given-names></name></person-group><article-title>Distinct differences in association of MHC class I with endoplasmic reticulum proteins in wild-type, and beta2-microglobulin- and TAP-deficient cell lines</article-title><source>Int Immunol</source><year>2001</year><volume>13</volume><fpage>1063</fpage><lpage>1073</lpage><pub-id pub-id-type="pmid">11470776</pub-id></element-citation></ref><ref id="b4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>JW</given-names></name><name><surname>Reeke</surname><given-names>GN</given-names><suffix>Jr</suffix></name></person-group><article-title>Three-dimensional structure of beta2-microglobulin</article-title><source>Proc Natl Acad Sci USA</source><year>1985</year><volume>82</volume><fpage>4225</fpage><lpage>4229</lpage><pub-id pub-id-type="pmid">3889925</pub-id></element-citation></ref><ref id="b5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>DP</given-names></name><name><surname>Radford</surname><given-names>SE</given-names></name></person-group><article-title>Role of the single disulphide bond of beta2-microglobulin in amyloidosis <italic>in vitro</italic></article-title><source>Protein Sci</source><year>2001</year><volume>10</volume><fpage>1775</fpage><lpage>1784</lpage><pub-id pub-id-type="pmid">11514668</pub-id></element-citation></ref><ref id="b6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katou</surname><given-names>H</given-names></name><name><surname>Kanno</surname><given-names>T</given-names></name><name><surname>Hoshino</surname><given-names>M</given-names></name><name><surname>Hagihara</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Hasegawa</surname><given-names>K</given-names></name><name><surname>Naiki</surname><given-names>H</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name></person-group><article-title>The role of disulfide bond in the amyloidogenic state of beta2-microglobulin studied by heteronuclear NMR</article-title><source>Protein Sci</source><year>2002</year><volume>11</volume><fpage>2218</fpage><lpage>2229</lpage><pub-id pub-id-type="pmid">12192077</pub-id></element-citation></ref><ref id="b7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdone</surname><given-names>G</given-names></name><name><surname>Corazza</surname><given-names>A</given-names></name><name><surname>Viglino</surname><given-names>P</given-names></name><name><surname>Pettirossi</surname><given-names>F</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Mangione</surname><given-names>P</given-names></name><name><surname>Andreola</surname><given-names>A</given-names></name><name><surname>Stoppini</surname><given-names>M</given-names></name><name><surname>Bellotti</surname><given-names>V</given-names></name><name><surname>Esposito</surname><given-names>G</given-names></name></person-group><article-title>The solution structure of human beta2-microglobulin reveals the prodromes of its amyloid transition</article-title><source>Protein Sci</source><year>2002</year><volume>11</volume><fpage>487</fpage><lpage>499</lpage><pub-id pub-id-type="pmid">11847272</pub-id></element-citation></ref><ref id="b8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corazza</surname><given-names>A</given-names></name><name><surname>Pettirossi</surname><given-names>F</given-names></name><name><surname>Viglino</surname><given-names>P</given-names></name><name><surname>Verdone</surname><given-names>G</given-names></name><name><surname>Garcia</surname><given-names>J</given-names></name><name><surname>Dumy</surname><given-names>P</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Mangione</surname><given-names>P</given-names></name><name><surname>Raimondi</surname><given-names>S</given-names></name><name><surname>Stoppini</surname><given-names>M</given-names></name><etal/></person-group><article-title>Properties of some variants of human beta2-microglobulin and amyloidogenesis</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>9176</fpage><lpage>9189</lpage><pub-id pub-id-type="pmid">14660575</pub-id></element-citation></ref><ref id="b9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eichner</surname><given-names>T</given-names></name><name><surname>Kalverda</surname><given-names>AP</given-names></name><name><surname>Thompson</surname><given-names>GS</given-names></name><name><surname>Homans</surname><given-names>SW</given-names></name><name><surname>Radford</surname><given-names>SE</given-names></name></person-group><article-title>Conformational conversion during amyloid formation at atomic resolution</article-title><source>Mol Cell</source><year>2011</year><volume>41</volume><fpage>161</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">21255727</pub-id></element-citation></ref><ref id="b10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>G</given-names></name><name><surname>Corazza</surname><given-names>A</given-names></name><name><surname>Viglino</surname><given-names>P</given-names></name><name><surname>Verdone</surname><given-names>G</given-names></name><name><surname>Pettirossi</surname><given-names>F</given-names></name><name><surname>Fogolari</surname><given-names>F</given-names></name><name><surname>Makek</surname><given-names>A</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Mangione</surname><given-names>P</given-names></name><name><surname>Stoppini</surname><given-names>M</given-names></name><etal/></person-group><article-title>Solution structure of beta2-microglobulin and insights into fibrillogenesis</article-title><source>Biochim Biophys Acta</source><year>2005</year><volume>1753</volume><fpage>76</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">16081329</pub-id></element-citation></ref><ref id="b11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinh</surname><given-names>CH</given-names></name><name><surname>Smith</surname><given-names>DP</given-names></name><name><surname>Kalverda</surname><given-names>AP</given-names></name><name><surname>Phillips</surname><given-names>SE</given-names></name><name><surname>Radford</surname><given-names>SE</given-names></name></person-group><article-title>Crystal structure of monomeric human beta2-microglobulin reveals clues to its amyloidogenic properties</article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>9771</fpage><lpage>9776</lpage><pub-id pub-id-type="pmid">12119416</pub-id></element-citation></ref><ref id="b12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwata</surname><given-names>K</given-names></name><name><surname>Matsuura</surname><given-names>T</given-names></name><name><surname>Sakurai</surname><given-names>K</given-names></name><name><surname>Nakagawa</surname><given-names>A</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name></person-group><article-title>High-resolution crystal structure of beta2-microglobulin formed at pH 7.0</article-title><source>J Biochem</source><year>2007</year><volume>142</volume><fpage>413</fpage><lpage>419</lpage><pub-id pub-id-type="pmid">17646174</pub-id></element-citation></ref><ref id="b13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricagno</surname><given-names>S</given-names></name><name><surname>Raimondi</surname><given-names>S</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Bellotti</surname><given-names>V</given-names></name><name><surname>Bolognesi</surname><given-names>M</given-names></name></person-group><article-title>Human beta2-microglobulin W60V mutant structure: implications for stability and amyloid aggregation</article-title><source>Biochem Biophys Res Commun</source><year>2009</year><volume>380</volume><fpage>543</fpage><lpage>547</lpage><pub-id pub-id-type="pmid">19284997</pub-id></element-citation></ref><ref id="b14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricagno</surname><given-names>S</given-names></name><name><surname>Colombo</surname><given-names>M</given-names></name><name><surname>de Rosa</surname><given-names>M</given-names></name><name><surname>Sangiovanni</surname><given-names>E</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Raimondi</surname><given-names>S</given-names></name><name><surname>Bellotti</surname><given-names>V</given-names></name><name><surname>Bolognesi</surname><given-names>M</given-names></name></person-group><article-title>DE loop mutations affect beta2-microglobulin stability and amyloid aggregation</article-title><source>Biochem Biophys Res Commun</source><year>2008</year><volume>377</volume><fpage>146</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">18835253</pub-id></element-citation></ref><ref id="b15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosano</surname><given-names>C</given-names></name><name><surname>Zuccotti</surname><given-names>S</given-names></name><name><surname>Mangione</surname><given-names>P</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Bellotti</surname><given-names>V</given-names></name><name><surname>Pettirossi</surname><given-names>F</given-names></name><name><surname>Corazza</surname><given-names>A</given-names></name><name><surname>Viglino</surname><given-names>P</given-names></name><name><surname>Esposito</surname><given-names>G</given-names></name><name><surname>Bolognesi</surname><given-names>M</given-names></name></person-group><article-title>Beta2-microglobulin H31Y variant 3D structure highlights the protein natural propensity towards intermolecular aggregation</article-title><source>J Mol Biol</source><year>2004</year><volume>335</volume><fpage>1051</fpage><lpage>1064</lpage><pub-id pub-id-type="pmid">14698299</pub-id></element-citation></ref><ref id="b16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>G</given-names></name><name><surname>Ricagno</surname><given-names>S</given-names></name><name><surname>Corazza</surname><given-names>A</given-names></name><name><surname>Rennella</surname><given-names>E</given-names></name><name><surname>Gumral</surname><given-names>D</given-names></name><name><surname>Mimmi</surname><given-names>MC</given-names></name><name><surname>Betto</surname><given-names>E</given-names></name><name><surname>Pucillo</surname><given-names>CE</given-names></name><name><surname>Fogolari</surname><given-names>F</given-names></name><name><surname>Viglino</surname><given-names>P</given-names></name><etal/></person-group><article-title>The controlling roles of Trp60 and Trp95 in beta2-microglobulin function, folding and amyloid aggregation properties</article-title><source>J Mol Biol</source><year>2008</year><volume>378</volume><fpage>887</fpage><lpage>897</lpage><pub-id pub-id-type="pmid">18395224</pub-id></element-citation></ref><ref id="b17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>AR</given-names></name><name><surname>Baker</surname><given-names>BM</given-names></name><name><surname>Ghosh</surname><given-names>P</given-names></name><name><surname>Biddison</surname><given-names>WE</given-names></name><name><surname>Wiley</surname><given-names>DC</given-names></name></person-group><article-title>The structure and stability of an HLA-A*0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site</article-title><source>J Immunol</source><year>2000</year><volume>164</volume><fpage>6398</fpage><lpage>6405</lpage><pub-id pub-id-type="pmid">10843695</pub-id></element-citation></ref><ref id="b18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodkinson</surname><given-names>JP</given-names></name><name><surname>Jahn</surname><given-names>TR</given-names></name><name><surname>Radford</surname><given-names>SE</given-names></name><name><surname>Ashcroft</surname><given-names>AE</given-names></name></person-group><article-title>HDX-ESI-MS reveals enhanced conformational dynamics of the amyloidogenic protein beta2-microglobulin upon release from the MHC-1</article-title><source>J Am Soc Mass Spectrom</source><year>2009</year><volume>20</volume><fpage>278</fpage><lpage>286</lpage><pub-id pub-id-type="pmid">18996721</pub-id></element-citation></ref><ref id="b19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rennella</surname><given-names>E</given-names></name><name><surname>Corazza</surname><given-names>A</given-names></name><name><surname>Fogolari</surname><given-names>F</given-names></name><name><surname>Viglino</surname><given-names>P</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Stoppini</surname><given-names>M</given-names></name><name><surname>Bellotti</surname><given-names>V</given-names></name><name><surname>Esposito</surname><given-names>G</given-names></name></person-group><article-title>Equilibrium unfolding thermodynamics of beta2-microglobulin analyzed through native-state H/D exchange</article-title><source>Biophys J</source><year>2009</year><volume>96</volume><fpage>169</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">18835891</pub-id></element-citation></ref><ref id="b20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rennella</surname><given-names>E</given-names></name><name><surname>Corazza</surname><given-names>A</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Fogolari</surname><given-names>F</given-names></name><name><surname>Viglino</surname><given-names>P</given-names></name><name><surname>Porcari</surname><given-names>R</given-names></name><name><surname>Verga</surname><given-names>L</given-names></name><name><surname>Stoppini</surname><given-names>M</given-names></name><name><surname>Bellotti</surname><given-names>V</given-names></name><name><surname>Esposito</surname><given-names>G</given-names></name></person-group><article-title>Folding and fibrillogenesis: clues from beta2-microglobulin</article-title><source>J Mol Biol</source><year>2010</year><volume>401</volume><fpage>286</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">20558175</pub-id></element-citation></ref><ref id="b21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Floege</surname><given-names>J</given-names></name><name><surname>Bartsch</surname><given-names>A</given-names></name><name><surname>Schulze</surname><given-names>M</given-names></name><name><surname>Shaldon</surname><given-names>S</given-names></name><name><surname>Koch</surname><given-names>KM</given-names></name><name><surname>Smeby</surname><given-names>LC</given-names></name></person-group><article-title>Clearance and synthesis rates of beta2-microglobulin in patients undergoing hemodialysis and in normal subjects</article-title><source>J Lab Clin Med</source><year>1991</year><volume>118</volume><fpage>153</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">1856578</pub-id></element-citation></ref><ref id="b22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Floege</surname><given-names>J</given-names></name><name><surname>Ketteler</surname><given-names>M</given-names></name></person-group><article-title>Beta2-microglobulin-derived amyloidosis: an update</article-title><source>Kidney Int Suppl</source><year>2001</year><volume>78</volume><fpage>S164</fpage><lpage>S171</lpage><pub-id pub-id-type="pmid">11169004</pub-id></element-citation></ref><ref id="b23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otsubo</surname><given-names>S</given-names></name><name><surname>Kimata</surname><given-names>N</given-names></name><name><surname>Okutsu</surname><given-names>I</given-names></name><name><surname>Oshikawa</surname><given-names>K</given-names></name><name><surname>Ueda</surname><given-names>S</given-names></name><name><surname>Sugimoto</surname><given-names>H</given-names></name><name><surname>Mitobe</surname><given-names>M</given-names></name><name><surname>Uchida</surname><given-names>K</given-names></name><name><surname>Otsubo</surname><given-names>K</given-names></name><name><surname>Nitta</surname><given-names>K</given-names></name><etal/></person-group><article-title>Characteristics of dialysis-related amyloidosis in patients on haemodialysis therapy for more than 30 years</article-title><source>Nephrol Dial Transplant</source><year>2009</year><volume>24</volume><fpage>1593</fpage><lpage>1598</lpage><pub-id pub-id-type="pmid">19096084</pub-id></element-citation></ref><ref id="b24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gejyo</surname><given-names>F</given-names></name><name><surname>Odani</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>T</given-names></name><name><surname>Honma</surname><given-names>N</given-names></name><name><surname>Saito</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Nakagawa</surname><given-names>Y</given-names></name><name><surname>Kobayashi</surname><given-names>H</given-names></name><name><surname>Maruyama</surname><given-names>Y</given-names></name><name><surname>Hirasawa</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Beta2-microglobulin: a new form of amyloid protein associated with chronic hemodialysis</article-title><source>Kidney Int</source><year>1986</year><volume>30</volume><fpage>385</fpage><lpage>390</lpage><pub-id pub-id-type="pmid">3537446</pub-id></element-citation></ref><ref id="b25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eichner</surname><given-names>T</given-names></name><name><surname>Radford</surname><given-names>SE</given-names></name></person-group><article-title>A generic mechanism of beta2-microglobulin amyloid assembly at neutral pH involving a specific proline switch</article-title><source>J Mol Biol</source><year>2009</year><volume>386</volume><fpage>1312</fpage><lpage>1326</lpage><pub-id pub-id-type="pmid">19452600</pub-id></element-citation></ref><ref id="b26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>SL</given-names></name><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Jahn</surname><given-names>TR</given-names></name><name><surname>Morten</surname><given-names>IJ</given-names></name><name><surname>Tennent</surname><given-names>GA</given-names></name><name><surname>Hewitt</surname><given-names>EW</given-names></name><name><surname>Radford</surname><given-names>SE</given-names></name></person-group><article-title>A systematic study of the effect of physiological factors on beta2-microglobulin amyloid formation at neutral pH</article-title><source>Biochemistry</source><year>2006</year><volume>45</volume><fpage>2311</fpage><lpage>2321</lpage><pub-id pub-id-type="pmid">16475820</pub-id></element-citation></ref><ref id="b27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Ypersele de Strihou</surname><given-names>C</given-names></name><name><surname>Jadoul</surname><given-names>M</given-names></name><name><surname>Malghem</surname><given-names>J</given-names></name><name><surname>Maldague</surname><given-names>B</given-names></name><name><surname>Jamart</surname><given-names>J</given-names></name></person-group><article-title>Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis</article-title><source>Kidney Int</source><year>1991</year><volume>39</volume><fpage>1012</fpage><lpage>1019</lpage><pub-id pub-id-type="pmid">2067196</pub-id></element-citation></ref><ref id="b28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davison</surname><given-names>AM</given-names></name></person-group><article-title>Beta2-microglobulin and amyloidosis: who is at risk?</article-title><source>Nephrol Dial Transplant</source><year>1995</year><volume>10</volume><issue>Suppl. 10</issue><fpage>48</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">8825433</pub-id></element-citation></ref><ref id="b29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zingraff</surname><given-names>JJ</given-names></name><name><surname>Noel</surname><given-names>LH</given-names></name><name><surname>Bardin</surname><given-names>T</given-names></name><name><surname>Atienza</surname><given-names>C</given-names></name><name><surname>Zins</surname><given-names>B</given-names></name><name><surname>Drueke</surname><given-names>TB</given-names></name><name><surname>Kuntz</surname><given-names>D</given-names></name></person-group><article-title>Beta2-microglobulin amyloidosis in chronic renal failure</article-title><source>N Engl J Med</source><year>1990</year><volume>323</volume><fpage>1070</fpage><lpage>1071</lpage><pub-id pub-id-type="pmid">2215569</pub-id></element-citation></ref><ref id="b30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriniere</surname><given-names>P</given-names></name><name><surname>Marie</surname><given-names>A</given-names></name><name><surname>el Esper</surname><given-names>N</given-names></name><name><surname>Fardellone</surname><given-names>P</given-names></name><name><surname>Deramond</surname><given-names>H</given-names></name><name><surname>Remond</surname><given-names>A</given-names></name><name><surname>Sebert</surname><given-names>JL</given-names></name><name><surname>Fournier</surname><given-names>A</given-names></name></person-group><article-title>Destructive spondyloarthropathy with beta2-microglobulin amyloid deposits in a uremic patient before chronic hemodialysis</article-title><source>Nephron</source><year>1991</year><volume>59</volume><fpage>654</fpage><lpage>657</lpage><pub-id pub-id-type="pmid">1766508</pub-id></element-citation></ref><ref id="b31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>D</given-names></name><name><surname>Norkrans</surname><given-names>G</given-names></name><name><surname>Wejstal</surname><given-names>R</given-names></name><name><surname>Reibnegger</surname><given-names>G</given-names></name><name><surname>Weiss</surname><given-names>G</given-names></name><name><surname>Weiland</surname><given-names>O</given-names></name><name><surname>Schvarcz</surname><given-names>R</given-names></name><name><surname>Fryden</surname><given-names>A</given-names></name><name><surname>Wachter</surname><given-names>H</given-names></name></person-group><article-title>Changes of serum neopterin, beta2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2b</article-title><source>Eur J Med</source><year>1992</year><volume>1</volume><fpage>196</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">1341444</pub-id></element-citation></ref><ref id="b32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>G</given-names></name><name><surname>Michelutti</surname><given-names>R</given-names></name><name><surname>Verdone</surname><given-names>G</given-names></name><name><surname>Viglino</surname><given-names>P</given-names></name><name><surname>Hernandez</surname><given-names>H</given-names></name><name><surname>Robinson</surname><given-names>CV</given-names></name><name><surname>Amoresano</surname><given-names>A</given-names></name><name><surname>Dal Piaz</surname><given-names>F</given-names></name><name><surname>Monti</surname><given-names>M</given-names></name><name><surname>Pucci</surname><given-names>P</given-names></name><etal/></person-group><article-title>Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation</article-title><source>Protein Sci</source><year>2000</year><volume>9</volume><fpage>831</fpage><lpage>845</lpage><pub-id pub-id-type="pmid">10850793</pub-id></element-citation></ref><ref id="b33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellotti</surname><given-names>V</given-names></name><name><surname>Gallieni</surname><given-names>M</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Brancaccio</surname><given-names>D</given-names></name></person-group><article-title>Dynamic of beta2-microglobulin fibril formation and reabsorption: the role of proteolysis</article-title><source>Semin Dial</source><year>2001</year><volume>14</volume><fpage>117</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">11264779</pub-id></element-citation></ref><ref id="b34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heegaard</surname><given-names>NH</given-names></name><name><surname>Roepstorff</surname><given-names>P</given-names></name><name><surname>Melberg</surname><given-names>SG</given-names></name><name><surname>Nissen</surname><given-names>MH</given-names></name></person-group><article-title>Cleaved beta2-microglobulin partially attains a conformation that has amyloidogenic features</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>11184</fpage><lpage>11189</lpage><pub-id pub-id-type="pmid">11801591</pub-id></element-citation></ref><ref id="b35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyata</surname><given-names>T</given-names></name><name><surname>Taneda</surname><given-names>S</given-names></name><name><surname>Kawai</surname><given-names>R</given-names></name><name><surname>Ueda</surname><given-names>Y</given-names></name><name><surname>Horiuchi</surname><given-names>S</given-names></name><name><surname>Hara</surname><given-names>M</given-names></name><name><surname>Maeda</surname><given-names>K</given-names></name><name><surname>Monnier</surname><given-names>VM</given-names></name></person-group><article-title>Identification of pentosidine as a native structure for advanced glycation end products in beta2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis</article-title><source>Proc Natl Acad Sci USA</source><year>1996</year><volume>93</volume><fpage>2353</fpage><lpage>2358</lpage><pub-id pub-id-type="pmid">8637877</pub-id></element-citation></ref><ref id="b36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyata</surname><given-names>T</given-names></name><name><surname>Inagi</surname><given-names>R</given-names></name><name><surname>Iida</surname><given-names>Y</given-names></name><name><surname>Sato</surname><given-names>M</given-names></name><name><surname>Yamada</surname><given-names>N</given-names></name><name><surname>Oda</surname><given-names>O</given-names></name><name><surname>Maeda</surname><given-names>K</given-names></name><name><surname>Seo</surname><given-names>H</given-names></name></person-group><article-title>Involvement of beta2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1</article-title><source>J Clin Invest</source><year>1994</year><volume>93</volume><fpage>521</fpage><lpage>528</lpage><pub-id pub-id-type="pmid">8113390</pub-id></element-citation></ref><ref id="b37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niwa</surname><given-names>T</given-names></name><name><surname>Katsuzaki</surname><given-names>T</given-names></name><name><surname>Miyazaki</surname><given-names>S</given-names></name><name><surname>Momoi</surname><given-names>T</given-names></name><name><surname>Akiba</surname><given-names>T</given-names></name><name><surname>Miyazaki</surname><given-names>T</given-names></name><name><surname>Nokura</surname><given-names>K</given-names></name><name><surname>Hayase</surname><given-names>F</given-names></name><name><surname>Tatemichi</surname><given-names>N</given-names></name><name><surname>Takei</surname><given-names>Y</given-names></name></person-group><article-title>Amyloid beta2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis</article-title><source>Kidney Int</source><year>1997</year><volume>51</volume><fpage>187</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">8995733</pub-id></element-citation></ref><ref id="b38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niwa</surname><given-names>T</given-names></name></person-group><article-title>Dialysis-related amyloidosis: pathogenesis focusing on AGE modification</article-title><source>Semin Dial</source><year>2001</year><volume>14</volume><fpage>123</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">11264780</pub-id></element-citation></ref><ref id="b39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capeillere-Blandin</surname><given-names>C</given-names></name><name><surname>Delaveau</surname><given-names>T</given-names></name><name><surname>Descamps-Latscha</surname><given-names>B</given-names></name></person-group><article-title>Structural modifications of human beta2-microglobulin treated with oxygen-derived radicals</article-title><source>Biochem J</source><year>1991</year><volume>277</volume><issue>Pt 1</issue><fpage>175</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">1649598</pub-id></element-citation></ref><ref id="b40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odani</surname><given-names>H</given-names></name><name><surname>Oyama</surname><given-names>R</given-names></name><name><surname>Titani</surname><given-names>K</given-names></name><name><surname>Ogawa</surname><given-names>H</given-names></name><name><surname>Saito</surname><given-names>A</given-names></name></person-group><article-title>Purification and complete amino acid sequence of novel beta2-microglobulin</article-title><source>Biochem Biophys Res Commun</source><year>1990</year><volume>168</volume><fpage>1223</fpage><lpage>1229</lpage><pub-id pub-id-type="pmid">2189404</pub-id></element-citation></ref><ref id="b41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Relini</surname><given-names>A</given-names></name><name><surname>Canale</surname><given-names>C</given-names></name><name><surname>De Stefano</surname><given-names>S</given-names></name><name><surname>Rolandi</surname><given-names>R</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Stoppini</surname><given-names>M</given-names></name><name><surname>Rossi</surname><given-names>A</given-names></name><name><surname>Fogolari</surname><given-names>F</given-names></name><name><surname>Corazza</surname><given-names>A</given-names></name><name><surname>Esposito</surname><given-names>G</given-names></name><etal/></person-group><article-title>Collagen plays an active role in the aggregation of beta2-microglobulin under physiopathological conditions of dialysis-related amyloidosis</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>16521</fpage><lpage>16529</lpage><pub-id pub-id-type="pmid">16601119</pub-id></element-citation></ref><ref id="b42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Relini</surname><given-names>A</given-names></name><name><surname>De Stefano</surname><given-names>S</given-names></name><name><surname>Torrassa</surname><given-names>S</given-names></name><name><surname>Cavalleri</surname><given-names>O</given-names></name><name><surname>Rolandi</surname><given-names>R</given-names></name><name><surname>Gliozzi</surname><given-names>A</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Raimondi</surname><given-names>S</given-names></name><name><surname>Marchese</surname><given-names>L</given-names></name><name><surname>Verga</surname><given-names>L</given-names></name><etal/></person-group><article-title>Heparin strongly enhances the formation of beta2-microglobulin amyloid fibrils in the presence of type I collagen</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>4912</fpage><lpage>4920</lpage><pub-id pub-id-type="pmid">18056266</pub-id></element-citation></ref><ref id="b43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Athanasou</surname><given-names>NA</given-names></name><name><surname>Puddle</surname><given-names>B</given-names></name><name><surname>Sallie</surname><given-names>B</given-names></name></person-group><article-title>Highly sulphated glycosaminoglycans in articular cartilage and other tissues containing beta2-microglobulin dialysis amyloid deposits</article-title><source>Nephrol Dial Transplant</source><year>1995</year><volume>10</volume><fpage>1672</fpage><lpage>1678</lpage><pub-id pub-id-type="pmid">8559488</pub-id></element-citation></ref><ref id="b44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Hasegawa</surname><given-names>K</given-names></name><name><surname>Yamaguchi</surname><given-names>I</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name><name><surname>Gejyo</surname><given-names>F</given-names></name><name><surname>Naiki</surname><given-names>H</given-names></name></person-group><article-title>Kinetic analysis of the polymerization and depolymerization of beta2-microglobulin-related amyloid fibrils <italic>in vitro</italic></article-title><source>Biochim Biophys Acta</source><year>2005</year><volume>1753</volume><fpage>34</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">16084781</pub-id></element-citation></ref><ref id="b45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pepys</surname><given-names>MB</given-names></name></person-group><article-title>Amyloidosis</article-title><source>Annu Rev Med</source><year>2006</year><volume>57</volume><fpage>223</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">16409147</pub-id></element-citation></ref><ref id="b46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>CJ</given-names></name><name><surname>Gelfand</surname><given-names>M</given-names></name><name><surname>Atreya</surname><given-names>C</given-names></name><name><surname>Miranker</surname><given-names>AD</given-names></name></person-group><article-title>Kidney dialysis-associated amyloidosis: a molecular role for copper in fiber formation</article-title><source>J Mol Biol</source><year>2001</year><volume>309</volume><fpage>339</fpage><lpage>345</lpage><pub-id pub-id-type="pmid">11371157</pub-id></element-citation></ref><ref id="b47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eakin</surname><given-names>CM</given-names></name><name><surname>Miranker</surname><given-names>AD</given-names></name></person-group><article-title>From chance to frequent encounters: origins of beta2-microglobulin fibrillogenesis</article-title><source>Biochim Biophys Acta</source><year>2005</year><volume>1753</volume><fpage>92</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">16226064</pub-id></element-citation></ref><ref id="b48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ookoshi</surname><given-names>T</given-names></name><name><surname>Hasegawa</surname><given-names>K</given-names></name><name><surname>Ohhashi</surname><given-names>Y</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Miyazaki</surname><given-names>R</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name><name><surname>Naiki</surname><given-names>H</given-names></name></person-group><article-title>Lysophospholipids induce the nucleation and extension of beta2-microglobulin-related amyloid fibrils at a neutral pH</article-title><source>Nephrol Dial Transplant</source><year>2008</year><volume>23</volume><fpage>3247</fpage><lpage>3255</lpage><pub-id pub-id-type="pmid">18467373</pub-id></element-citation></ref><ref id="b49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pal-Gabor</surname><given-names>H</given-names></name><name><surname>Gombos</surname><given-names>L</given-names></name><name><surname>Micsonai</surname><given-names>A</given-names></name><name><surname>Kovacs</surname><given-names>E</given-names></name><name><surname>Petrik</surname><given-names>E</given-names></name><name><surname>Kovacs</surname><given-names>J</given-names></name><name><surname>Graf</surname><given-names>L</given-names></name><name><surname>Fidy</surname><given-names>J</given-names></name><name><surname>Naiki</surname><given-names>H</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Mechanism of lysophosphatidic acid-induced amyloid fibril formation of beta2-microglobulin <italic>in vitro</italic> under physiological conditions</article-title><source>Biochemistry</source><year>2009</year><volume>48</volume><fpage>5689</fpage><lpage>5699</lpage><pub-id pub-id-type="pmid">19432419</pub-id></element-citation></ref><ref id="b50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasegawa</surname><given-names>K</given-names></name><name><surname>Tsutsumi-Yasuhara</surname><given-names>S</given-names></name><name><surname>Ookoshi</surname><given-names>T</given-names></name><name><surname>Ohhashi</surname><given-names>Y</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Miyazaki</surname><given-names>R</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name><name><surname>Naiki</surname><given-names>H</given-names></name></person-group><article-title>Growth of beta2-microglobulin-related amyloid fibrils by non-esterified fatty acids at a neutral pH</article-title><source>Biochem J</source><year>2008</year><volume>416</volume><fpage>307</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">18637792</pub-id></element-citation></ref><ref id="b51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Hasegawa</surname><given-names>K</given-names></name><name><surname>Yamaguchi</surname><given-names>I</given-names></name><name><surname>Tsutsumi</surname><given-names>S</given-names></name><name><surname>Kardos</surname><given-names>J</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name><name><surname>Gejyo</surname><given-names>F</given-names></name><name><surname>Naiki</surname><given-names>H</given-names></name></person-group><article-title>Low concentrations of sodium dodecyl sulfate induce the extension of beta2-microglobulin-related amyloid fibrils at a neutral pH</article-title><source>Biochemistry</source><year>2004</year><volume>43</volume><fpage>11075</fpage><lpage>11082</lpage><pub-id pub-id-type="pmid">15323566</pub-id></element-citation></ref><ref id="b52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srikanth</surname><given-names>R</given-names></name><name><surname>Mendoza</surname><given-names>VL</given-names></name><name><surname>Bridgewater</surname><given-names>JD</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Vachet</surname><given-names>RW</given-names></name></person-group><article-title>Copper binding to beta2-microglobulin and its pre-amyloid oligomers</article-title><source>Biochemistry</source><year>2009</year><volume>48</volume><fpage>9871</fpage><lpage>9881</lpage><pub-id pub-id-type="pmid">19754160</pub-id></element-citation></ref><ref id="b53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calabrese</surname><given-names>MF</given-names></name><name><surname>Miranker</surname><given-names>AD</given-names></name></person-group><article-title>Metal binding sheds light on mechanisms of amyloid assembly</article-title><source>Prion</source><year>2009</year><volume>3</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">19377278</pub-id></element-citation></ref><ref id="b54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaho</surname><given-names>DV</given-names></name><name><surname>Miranker</surname><given-names>AD</given-names></name></person-group><article-title>Delineating the conformational elements responsible for Cu(2+)-induced oligomerization of beta2-microglobulin</article-title><source>Biochemistry</source><year>2009</year><volume>48</volume><fpage>6610</fpage><lpage>6617</lpage><pub-id pub-id-type="pmid">19518133</pub-id></element-citation></ref><ref id="b55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calabrese</surname><given-names>MF</given-names></name><name><surname>Eakin</surname><given-names>CM</given-names></name><name><surname>Wang</surname><given-names>JM</given-names></name><name><surname>Miranker</surname><given-names>AD</given-names></name></person-group><article-title>A regulatable switch mediates self-association in an immunoglobulin fold</article-title><source>Nat Struct Mol Biol</source><year>2008</year><volume>15</volume><fpage>965</fpage><lpage>971</lpage><pub-id pub-id-type="pmid">19172750</pub-id></element-citation></ref><ref id="b56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antwi</surname><given-names>K</given-names></name><name><surname>Mahar</surname><given-names>M</given-names></name><name><surname>Srikanth</surname><given-names>R</given-names></name><name><surname>Olbris</surname><given-names>MR</given-names></name><name><surname>Tyson</surname><given-names>JF</given-names></name><name><surname>Vachet</surname><given-names>RW</given-names></name></person-group><article-title>Cu(II) organizes beta2-microglobulin oligomers but is released upon amyloid formation</article-title><source>Protein Sci</source><year>2008</year><volume>17</volume><fpage>748</fpage><lpage>759</lpage><pub-id pub-id-type="pmid">18305198</pub-id></element-citation></ref><ref id="b57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calabrese</surname><given-names>MF</given-names></name><name><surname>Miranker</surname><given-names>AD</given-names></name></person-group><article-title>Formation of a stable oligomer of beta2-microglobulin requires only transient encounter with Cu(II)</article-title><source>J Mol Biol</source><year>2007</year><volume>367</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17254602</pub-id></element-citation></ref><ref id="b58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eakin</surname><given-names>CM</given-names></name><name><surname>Berman</surname><given-names>AJ</given-names></name><name><surname>Miranker</surname><given-names>AD</given-names></name></person-group><article-title>A native to amyloidogenic transition regulated by a backbone trigger</article-title><source>Nat Struct Mol Biol</source><year>2006</year><volume>13</volume><fpage>202</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">16491088</pub-id></element-citation></ref><ref id="b59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>NJ</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name><name><surname>Singh</surname><given-names>D</given-names></name><name><surname>Cieplak</surname><given-names>P</given-names></name></person-group><article-title>Molecular basis for the Cu2+ binding-induced destabilization of beta2-microglobulin revealed by molecular dynamics simulation</article-title><source>Biophys J</source><year>2006</year><volume>90</volume><fpage>3865</fpage><lpage>3879</lpage><pub-id pub-id-type="pmid">16513784</pub-id></element-citation></ref><ref id="b60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Yamaguchi</surname><given-names>I</given-names></name><name><surname>Hasegawa</surname><given-names>K</given-names></name><name><surname>Tsutsumi</surname><given-names>S</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name><name><surname>Gejyo</surname><given-names>F</given-names></name><name><surname>Naiki</surname><given-names>H</given-names></name></person-group><article-title>Glycosaminoglycans enhance the trifluoroethanol-induced extension of beta2-microglobulin-related amyloid fibrils at a neutral pH</article-title><source>J Am Soc Nephrol</source><year>2004</year><volume>15</volume><fpage>126</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">14694164</pub-id></element-citation></ref><ref id="b61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Rossi</surname><given-names>A</given-names></name><name><surname>Mangione</surname><given-names>P</given-names></name><name><surname>Raimondi</surname><given-names>S</given-names></name><name><surname>Marini</surname><given-names>S</given-names></name><name><surname>Stoppini</surname><given-names>M</given-names></name><name><surname>Corazza</surname><given-names>A</given-names></name><name><surname>Viglino</surname><given-names>P</given-names></name><name><surname>Esposito</surname><given-names>G</given-names></name><name><surname>Cetta</surname><given-names>G</given-names></name><etal/></person-group><article-title>Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen</article-title><source>Protein Sci</source><year>2005</year><volume>14</volume><fpage>696</fpage><lpage>702</lpage><pub-id pub-id-type="pmid">15689502</pub-id></element-citation></ref><ref id="b62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>DP</given-names></name><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Serpell</surname><given-names>LC</given-names></name><name><surname>Sunde</surname><given-names>M</given-names></name><name><surname>Radford</surname><given-names>SE</given-names></name></person-group><article-title>A systematic investigation into the effect of protein destabilisation on beta2-microglobulin amyloid formation</article-title><source>J Mol Biol</source><year>2003</year><volume>330</volume><fpage>943</fpage><lpage>954</lpage><pub-id pub-id-type="pmid">12860118</pub-id></element-citation></ref><ref id="b63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armen</surname><given-names>RS</given-names></name><name><surname>Daggett</surname><given-names>V</given-names></name></person-group><article-title>Characterization of two distinct beta2-microglobulin unfolding intermediates that may lead to amyloid fibrils of different morphology</article-title><source>Biochemistry</source><year>2005</year><volume>44</volume><fpage>16098</fpage><lpage>16107</lpage><pub-id pub-id-type="pmid">16331970</pub-id></element-citation></ref><ref id="b64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armen</surname><given-names>RS</given-names></name><name><surname>DeMarco</surname><given-names>ML</given-names></name><name><surname>Alonso</surname><given-names>DO</given-names></name><name><surname>Daggett</surname><given-names>V</given-names></name></person-group><article-title>Pauling and Corey's alpha-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease</article-title><source>Proc Natl Acad Sci USA</source><year>2004</year><volume>101</volume><fpage>11622</fpage><lpage>11627</lpage><pub-id pub-id-type="pmid">15280548</pub-id></element-citation></ref><ref id="b65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fogolari</surname><given-names>F</given-names></name><name><surname>Corazza</surname><given-names>A</given-names></name><name><surname>Viglino</surname><given-names>P</given-names></name><name><surname>Zuccato</surname><given-names>P</given-names></name><name><surname>Pieri</surname><given-names>L</given-names></name><name><surname>Faccioli</surname><given-names>P</given-names></name><name><surname>Bellotti</surname><given-names>V</given-names></name><name><surname>Esposito</surname><given-names>G</given-names></name></person-group><article-title>Molecular dynamics simulation suggests possible interaction patterns at early steps of beta2-microglobulin aggregation</article-title><source>Biophys J</source><year>2007</year><volume>92</volume><fpage>1673</fpage><lpage>1681</lpage><pub-id pub-id-type="pmid">17158575</pub-id></element-citation></ref><ref id="b66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corazza</surname><given-names>A</given-names></name><name><surname>Rennella</surname><given-names>E</given-names></name><name><surname>Schanda</surname><given-names>P</given-names></name><name><surname>Mimmi</surname><given-names>MC</given-names></name><name><surname>Cutuil</surname><given-names>T</given-names></name><name><surname>Raimondi</surname><given-names>S</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Fogolari</surname><given-names>F</given-names></name><name><surname>Viglino</surname><given-names>P</given-names></name><name><surname>Frydman</surname><given-names>L</given-names></name><etal/></person-group><article-title>Native-unlike long-lived intermediates along the folding pathway of the amyloidogenic protein beta2-microglobulin revealed by real-time two-dimensional NMR</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>5827</fpage><lpage>5835</lpage><pub-id pub-id-type="pmid">20028983</pub-id></element-citation></ref><ref id="b67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahn</surname><given-names>TR</given-names></name><name><surname>Parker</surname><given-names>MJ</given-names></name><name><surname>Homans</surname><given-names>SW</given-names></name><name><surname>Radford</surname><given-names>SE</given-names></name></person-group><article-title>Amyloid formation under physiological conditions proceeds via a native-like folding intermediate</article-title><source>Nat Struct Mol Biol</source><year>2006</year><volume>13</volume><fpage>195</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">16491092</pub-id></element-citation></ref><ref id="b68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kameda</surname><given-names>A</given-names></name><name><surname>Hoshino</surname><given-names>M</given-names></name><name><surname>Higurashi</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Naiki</surname><given-names>H</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name></person-group><article-title>Nuclear magnetic resonance characterization of the refolding intermediate of beta2-microglobulin trapped by non-native prolyl peptide bond</article-title><source>J Mol Biol</source><year>2005</year><volume>348</volume><fpage>383</fpage><lpage>397</lpage><pub-id pub-id-type="pmid">15811375</pub-id></element-citation></ref><ref id="b69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakata</surname><given-names>M</given-names></name><name><surname>Chatani</surname><given-names>E</given-names></name><name><surname>Kameda</surname><given-names>A</given-names></name><name><surname>Sakurai</surname><given-names>K</given-names></name><name><surname>Naiki</surname><given-names>H</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name></person-group><article-title>Kinetic coupling of folding and prolyl isomerization of beta2-microglobulin studied by mutational analysis</article-title><source>J Mol Biol</source><year>2008</year><volume>382</volume><fpage>1242</fpage><lpage>1255</lpage><pub-id pub-id-type="pmid">18708068</pub-id></element-citation></ref><ref id="b70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pawar</surname><given-names>AP</given-names></name><name><surname>Dubay</surname><given-names>KF</given-names></name><name><surname>Zurdo</surname><given-names>J</given-names></name><name><surname>Chiti</surname><given-names>F</given-names></name><name><surname>Vendruscolo</surname><given-names>M</given-names></name><name><surname>Dobson</surname><given-names>CM</given-names></name></person-group><article-title>Prediction of &#x02018;aggregation-prone&#x02019; and &#x02018;aggregation-susceptible&#x02019; regions in proteins associated with neurodegenerative diseases</article-title><source>J Mol Biol</source><year>2005</year><volume>350</volume><fpage>379</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">15925383</pub-id></element-citation></ref><ref id="b71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canet</surname><given-names>D</given-names></name><name><surname>Last</surname><given-names>AM</given-names></name><name><surname>Tito</surname><given-names>P</given-names></name><name><surname>Sunde</surname><given-names>M</given-names></name><name><surname>Spencer</surname><given-names>A</given-names></name><name><surname>Archer</surname><given-names>DB</given-names></name><name><surname>Redfield</surname><given-names>C</given-names></name><name><surname>Robinson</surname><given-names>CV</given-names></name><name><surname>Dobson</surname><given-names>CM</given-names></name></person-group><article-title>Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme</article-title><source>Nat Struct Biol</source><year>2002</year><volume>9</volume><fpage>308</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">11887182</pub-id></element-citation></ref><ref id="b72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumoulin</surname><given-names>M</given-names></name><name><surname>Canet</surname><given-names>D</given-names></name><name><surname>Last</surname><given-names>AM</given-names></name><name><surname>Pardon</surname><given-names>E</given-names></name><name><surname>Archer</surname><given-names>DB</given-names></name><name><surname>Muyldermans</surname><given-names>S</given-names></name><name><surname>Wyns</surname><given-names>L</given-names></name><name><surname>Matagne</surname><given-names>A</given-names></name><name><surname>Robinson</surname><given-names>CV</given-names></name><name><surname>Redfield</surname><given-names>C</given-names></name><etal/></person-group><article-title>Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations</article-title><source>J Mol Biol</source><year>2005</year><volume>346</volume><fpage>773</fpage><lpage>788</lpage><pub-id pub-id-type="pmid">15713462</pub-id></element-citation></ref><ref id="b73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plakoutsi</surname><given-names>G</given-names></name><name><surname>Taddei</surname><given-names>N</given-names></name><name><surname>Stefani</surname><given-names>M</given-names></name><name><surname>Chiti</surname><given-names>F</given-names></name></person-group><article-title>Aggregation of the acylphosphatase from <italic>Sulfolobus solfataricus</italic>: the folded and partially unfolded states can both be precursors for amyloid formation</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>14111</fpage><lpage>14119</lpage><pub-id pub-id-type="pmid">14724277</pub-id></element-citation></ref><ref id="b74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plakoutsi</surname><given-names>G</given-names></name><name><surname>Bemporad</surname><given-names>F</given-names></name><name><surname>Calamai</surname><given-names>M</given-names></name><name><surname>Taddei</surname><given-names>N</given-names></name><name><surname>Dobson</surname><given-names>CM</given-names></name><name><surname>Chiti</surname><given-names>F</given-names></name></person-group><article-title>Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates</article-title><source>J Mol Biol</source><year>2005</year><volume>351</volume><fpage>910</fpage><lpage>922</lpage><pub-id pub-id-type="pmid">16024042</pub-id></element-citation></ref><ref id="b75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colon</surname><given-names>W</given-names></name><name><surname>Kelly</surname><given-names>JW</given-names></name></person-group><article-title>Partial denaturation of transthyretin is sufficient for amyloid fibril formation <italic>in vitro</italic></article-title><source>Biochemistry</source><year>1992</year><volume>31</volume><fpage>8654</fpage><lpage>8660</lpage><pub-id pub-id-type="pmid">1390650</pub-id></element-citation></ref><ref id="b76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>Z</given-names></name><name><surname>Colon</surname><given-names>W</given-names></name><name><surname>Kelly</surname><given-names>JW</given-names></name></person-group><article-title>The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid</article-title><source>Biochemistry</source><year>1996</year><volume>35</volume><fpage>6470</fpage><lpage>6482</lpage><pub-id pub-id-type="pmid">8639594</pub-id></element-citation></ref><ref id="b77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Cho</surname><given-names>HS</given-names></name><name><surname>Lashuel</surname><given-names>HA</given-names></name><name><surname>Kelly</surname><given-names>JW</given-names></name><name><surname>Wemmer</surname><given-names>DE</given-names></name></person-group><article-title>A glimpse of a possible amyloidogenic intermediate of transthyretin</article-title><source>Nat Struct Biol</source><year>2000</year><volume>7</volume><fpage>754</fpage><lpage>757</lpage><pub-id pub-id-type="pmid">10966644</pub-id></element-citation></ref><ref id="b78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elam</surname><given-names>JS</given-names></name><name><surname>Taylor</surname><given-names>AB</given-names></name><name><surname>Strange</surname><given-names>R</given-names></name><name><surname>Antonyuk</surname><given-names>S</given-names></name><name><surname>Doucette</surname><given-names>PA</given-names></name><name><surname>Rodriguez</surname><given-names>JA</given-names></name><name><surname>Hasnain</surname><given-names>SS</given-names></name><name><surname>Hayward</surname><given-names>LJ</given-names></name><name><surname>Valentine</surname><given-names>JS</given-names></name><name><surname>Yeates</surname><given-names>TO</given-names></name><etal/></person-group><article-title>Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS</article-title><source>Nat Struct Biol</source><year>2003</year><volume>10</volume><fpage>461</fpage><lpage>467</lpage><pub-id pub-id-type="pmid">12754496</pub-id></element-citation></ref><ref id="b79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banci</surname><given-names>L</given-names></name><name><surname>Bertini</surname><given-names>I</given-names></name><name><surname>D'Amelio</surname><given-names>N</given-names></name><name><surname>Gaggelli</surname><given-names>E</given-names></name><name><surname>Libralesso</surname><given-names>E</given-names></name><name><surname>Matecko</surname><given-names>I</given-names></name><name><surname>Turano</surname><given-names>P</given-names></name><name><surname>Valentine</surname><given-names>JS</given-names></name></person-group><article-title>Fully metallated S134N Cu,Zn-superoxide dismutase displays abnormal mobility and intermolecular contacts in solution</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>35815</fpage><lpage>35821</lpage><pub-id pub-id-type="pmid">16105836</pub-id></element-citation></ref><ref id="b80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordlund</surname><given-names>A</given-names></name><name><surname>Oliveberg</surname><given-names>M</given-names></name></person-group><article-title>Folding of Cu/Zn superoxide dismutase suggests structural hotspots for gain of neurotoxic function in ALS: parallels to precursors in amyloid disease</article-title><source>Proc Natl Acad Sci USA</source><year>2006</year><volume>103</volume><fpage>10218</fpage><lpage>10223</lpage><pub-id pub-id-type="pmid">16798882</pub-id></element-citation></ref><ref id="b81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiti</surname><given-names>F</given-names></name><name><surname>Mangione</surname><given-names>P</given-names></name><name><surname>Andreola</surname><given-names>A</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Stefani</surname><given-names>M</given-names></name><name><surname>Dobson</surname><given-names>CM</given-names></name><name><surname>Bellotti</surname><given-names>V</given-names></name><name><surname>Taddei</surname><given-names>N</given-names></name></person-group><article-title>Detection of two partially structured species in the folding process of the amyloidogenic protein beta2-microglobulin</article-title><source>J Mol Biol</source><year>2001</year><volume>307</volume><fpage>379</fpage><lpage>391</lpage><pub-id pub-id-type="pmid">11243826</pub-id></element-citation></ref><ref id="b82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiti</surname><given-names>F</given-names></name><name><surname>De Lorenzi</surname><given-names>E</given-names></name><name><surname>Grossi</surname><given-names>S</given-names></name><name><surname>Mangione</surname><given-names>P</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Caccialanza</surname><given-names>G</given-names></name><name><surname>Dobson</surname><given-names>CM</given-names></name><name><surname>Merlini</surname><given-names>G</given-names></name><name><surname>Ramponi</surname><given-names>G</given-names></name><name><surname>Bellotti</surname><given-names>V</given-names></name></person-group><article-title>A partially structured species of beta2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>46714</fpage><lpage>46721</lpage><pub-id pub-id-type="pmid">11590172</pub-id></element-citation></ref><ref id="b83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heegaard</surname><given-names>NH</given-names></name><name><surname>Sen</surname><given-names>JW</given-names></name><name><surname>Kaarsholm</surname><given-names>NC</given-names></name><name><surname>Nissen</surname><given-names>MH</given-names></name></person-group><article-title>Conformational intermediate of the amyloidogenic protein beta2-microglobulin at neutral pH</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>32657</fpage><lpage>32662</lpage><pub-id pub-id-type="pmid">11418618</pub-id></element-citation></ref><ref id="b84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benyamini</surname><given-names>H</given-names></name><name><surname>Gunasekaran</surname><given-names>K</given-names></name><name><surname>Wolfson</surname><given-names>H</given-names></name><name><surname>Nussinov</surname><given-names>R</given-names></name></person-group><article-title>Beta2-microglobulin amyloidosis: insights from conservation analysis and fibril modelling by protein docking techniques</article-title><source>J Mol Biol</source><year>2003</year><volume>330</volume><fpage>159</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">12818210</pub-id></element-citation></ref><ref id="b85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goto</surname><given-names>Y</given-names></name><name><surname>Azuma</surname><given-names>T</given-names></name><name><surname>Hamaguchi</surname><given-names>K</given-names></name></person-group><article-title>Refolding of the immunoglobulin light chain</article-title><source>J Biochem</source><year>1979</year><volume>85</volume><fpage>1427</fpage><lpage>1438</lpage><pub-id pub-id-type="pmid">110798</pub-id></element-citation></ref><ref id="b86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goto</surname><given-names>Y</given-names></name><name><surname>Hamaguchi</surname><given-names>K</given-names></name></person-group><article-title>Unfolding and refolding of the reduced constant fragment of the immunoglobulin light chain. Kinetic role of the intrachain disulfide bond</article-title><source>J Mol Biol</source><year>1982</year><volume>156</volume><fpage>911</fpage><lpage>926</lpage><pub-id pub-id-type="pmid">6811754</pub-id></element-citation></ref><ref id="b87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goto</surname><given-names>Y</given-names></name><name><surname>Hamaguchi</surname><given-names>K</given-names></name></person-group><article-title>Unfolding and refolding of the constant fragment of the immunoglobulin light chain</article-title><source>J Mol Biol</source><year>1982</year><volume>156</volume><fpage>891</fpage><lpage>910</lpage><pub-id pub-id-type="pmid">6811753</pub-id></element-citation></ref><ref id="b88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thies</surname><given-names>MJ</given-names></name><name><surname>Mayer</surname><given-names>J</given-names></name><name><surname>Augustine</surname><given-names>JG</given-names></name><name><surname>Frederick</surname><given-names>CA</given-names></name><name><surname>Lilie</surname><given-names>H</given-names></name><name><surname>Buchner</surname><given-names>J</given-names></name></person-group><article-title>Folding and association of the antibody domain CH3: prolyl isomerization precedes dimerization</article-title><source>J Mol Biol</source><year>1999</year><volume>293</volume><fpage>67</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">10512716</pub-id></element-citation></ref><ref id="b89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feige</surname><given-names>MJ</given-names></name><name><surname>Walter</surname><given-names>S</given-names></name><name><surname>Buchner</surname><given-names>J</given-names></name></person-group><article-title>Folding mechanism of the CH2 antibody domain</article-title><source>J Mol Biol</source><year>2004</year><volume>344</volume><fpage>107</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">15504405</pub-id></element-citation></ref><ref id="b90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feige</surname><given-names>MJ</given-names></name><name><surname>Groscurth</surname><given-names>S</given-names></name><name><surname>Marcinowski</surname><given-names>M</given-names></name><name><surname>Yew</surname><given-names>ZT</given-names></name><name><surname>Truffault</surname><given-names>V</given-names></name><name><surname>Paci</surname><given-names>E</given-names></name><name><surname>Kessler</surname><given-names>H</given-names></name><name><surname>Buchner</surname><given-names>J</given-names></name></person-group><article-title>The structure of a folding intermediate provides insight into differences in immunoglobulin amyloidogenicity</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>13373</fpage><lpage>13378</lpage><pub-id pub-id-type="pmid">18768806</pub-id></element-citation></ref><ref id="b91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feige</surname><given-names>MJ</given-names></name><name><surname>Groscurth</surname><given-names>S</given-names></name><name><surname>Marcinowski</surname><given-names>M</given-names></name><name><surname>Shimizu</surname><given-names>Y</given-names></name><name><surname>Kessler</surname><given-names>H</given-names></name><name><surname>Hendershot</surname><given-names>LM</given-names></name><name><surname>Buchner</surname><given-names>J</given-names></name></person-group><article-title>An unfolded CH1 domain controls the assembly and secretion of IgG antibodies</article-title><source>Mol Cell</source><year>2009</year><volume>34</volume><fpage>569</fpage><lpage>579</lpage><pub-id pub-id-type="pmid">19524537</pub-id></element-citation></ref><ref id="b92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villanueva</surname><given-names>J</given-names></name><name><surname>Hoshino</surname><given-names>M</given-names></name><name><surname>Katou</surname><given-names>H</given-names></name><name><surname>Kardos</surname><given-names>J</given-names></name><name><surname>Hasegawa</surname><given-names>K</given-names></name><name><surname>Naiki</surname><given-names>H</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name></person-group><article-title>Increase in the conformational flexibility of beta2-microglobulin upon copper binding: a possible role for copper in dialysis-related amyloidosis</article-title><source>Protein Sci</source><year>2004</year><volume>13</volume><fpage>797</fpage><lpage>809</lpage><pub-id pub-id-type="pmid">14767076</pub-id></element-citation></ref><ref id="b93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borysik</surname><given-names>AJ</given-names></name><name><surname>Morten</surname><given-names>IJ</given-names></name><name><surname>Radford</surname><given-names>SE</given-names></name><name><surname>Hewitt</surname><given-names>EW</given-names></name></person-group><article-title>Specific glycosaminoglycans promote unseeded amyloid formation from beta2-microglobulin under physiological conditions</article-title><source>Kidney Int</source><year>2007</year><volume>72</volume><fpage>174</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">17495865</pub-id></element-citation></ref><ref id="b94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kihara</surname><given-names>M</given-names></name><name><surname>Chatani</surname><given-names>E</given-names></name><name><surname>Sakai</surname><given-names>M</given-names></name><name><surname>Hasegawa</surname><given-names>K</given-names></name><name><surname>Naiki</surname><given-names>H</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name></person-group><article-title>Seeding-dependent maturation of beta2-microglobulin amyloid fibrils at neutral pH</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>12012</fpage><lpage>12018</lpage><pub-id pub-id-type="pmid">15659393</pub-id></element-citation></ref><ref id="b95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohhashi</surname><given-names>Y</given-names></name><name><surname>Kihara</surname><given-names>M</given-names></name><name><surname>Naiki</surname><given-names>H</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name></person-group><article-title>Ultrasonication-induced amyloid fibril formation of beta2-microglobulin</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>32843</fpage><lpage>32848</lpage><pub-id pub-id-type="pmid">16046408</pub-id></element-citation></ref><ref id="b96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasahara</surname><given-names>K</given-names></name><name><surname>Yagi</surname><given-names>H</given-names></name><name><surname>Naiki</surname><given-names>H</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name></person-group><article-title>Heat-induced conversion of beta2-microglobulin and hen egg-white lysozyme into amyloid fibrils</article-title><source>J Mol Biol</source><year>2007</year><volume>372</volume><fpage>981</fpage><lpage>991</lpage><pub-id pub-id-type="pmid">17681531</pub-id></element-citation></ref><ref id="b97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasahara</surname><given-names>K</given-names></name><name><surname>Yagi</surname><given-names>H</given-names></name><name><surname>Sakai</surname><given-names>M</given-names></name><name><surname>Naiki</surname><given-names>H</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name></person-group><article-title>Amyloid nucleation triggered by agitation of beta2-microglobulin under acidic and neutral pH conditions</article-title><source>Biochemistry</source><year>2008</year><volume>47</volume><fpage>2650</fpage><lpage>2660</lpage><pub-id pub-id-type="pmid">18211100</pub-id></element-citation></ref><ref id="b98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>DP</given-names></name><name><surname>Radford</surname><given-names>SE</given-names></name></person-group><article-title>Role of the N and C-terminal strands of beta2-microglobulin in amyloid formation at neutral pH</article-title><source>J Mol Biol</source><year>2003</year><volume>330</volume><fpage>935</fpage><lpage>941</lpage><pub-id pub-id-type="pmid">12860117</pub-id></element-citation></ref><ref id="b99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piazza</surname><given-names>R</given-names></name><name><surname>Pierno</surname><given-names>M</given-names></name><name><surname>Iacopini</surname><given-names>S</given-names></name><name><surname>Mangione</surname><given-names>P</given-names></name><name><surname>Esposito</surname><given-names>G</given-names></name><name><surname>Bellotti</surname><given-names>V</given-names></name></person-group><article-title>Micro-heterogeneity and aggregation in beta2-microglobulin solutions: effects of temperature, pH, and conformational variant addition</article-title><source>Eur Biophys J</source><year>2006</year><volume>35</volume><fpage>439</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">16520957</pub-id></element-citation></ref><ref id="b100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Stoppini</surname><given-names>M</given-names></name><name><surname>Tennent</surname><given-names>GA</given-names></name><name><surname>Relini</surname><given-names>A</given-names></name><name><surname>Marchese</surname><given-names>L</given-names></name><name><surname>Raimondi</surname><given-names>S</given-names></name><name><surname>Monti</surname><given-names>M</given-names></name><name><surname>Marini</surname><given-names>S</given-names></name><name><surname>Ostergaard</surname><given-names>O</given-names></name><name><surname>Heegaard</surname><given-names>NH</given-names></name><etal/></person-group><article-title>Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in <italic>ex vivo</italic> amyloid fibrils of two patients affected by dialysis-related amyloidosis</article-title><source>Protein Sci</source><year>2007</year><volume>16</volume><fpage>343</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">17242436</pub-id></element-citation></ref><ref id="b101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colombo</surname><given-names>M</given-names></name><name><surname>Ricagno</surname><given-names>S</given-names></name><name><surname>Barbiroli</surname><given-names>A</given-names></name><name><surname>Santambrogio</surname><given-names>C</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Raimondi</surname><given-names>S</given-names></name><name><surname>Bonomi</surname><given-names>F</given-names></name><name><surname>Grandori</surname><given-names>R</given-names></name><name><surname>Bellotti</surname><given-names>V</given-names></name><name><surname>Bolognesi</surname><given-names>M</given-names></name></person-group><article-title>The effects of an ideal beta-turn on beta2-microglobulin fold stability</article-title><source>J Biochem</source><year>2011</year><comment>in press. doi:<ext-link ext-link-type="doi" xlink:href="10.1093/jb/mvr034">10.1093/jb/mvr034</ext-link></comment></element-citation></ref><ref id="b102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heegaard</surname><given-names>NH</given-names></name><name><surname>Jorgensen</surname><given-names>TJ</given-names></name><name><surname>Rozlosnik</surname><given-names>N</given-names></name><name><surname>Corlin</surname><given-names>DB</given-names></name><name><surname>Pedersen</surname><given-names>JS</given-names></name><name><surname>Tempesta</surname><given-names>AG</given-names></name><name><surname>Roepstorff</surname><given-names>P</given-names></name><name><surname>Bauer</surname><given-names>R</given-names></name><name><surname>Nissen</surname><given-names>MH</given-names></name></person-group><article-title>Unfolding, aggregation, and seeded amyloid formation of lysine-58-cleaved beta2-microglobulin</article-title><source>Biochemistry</source><year>2005</year><volume>44</volume><fpage>4397</fpage><lpage>4407</lpage><pub-id pub-id-type="pmid">15766269</pub-id></element-citation></ref><ref id="b103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mimmi</surname><given-names>MC</given-names></name><name><surname>Jorgensen</surname><given-names>TJ</given-names></name><name><surname>Pettirossi</surname><given-names>F</given-names></name><name><surname>Corazza</surname><given-names>A</given-names></name><name><surname>Viglino</surname><given-names>P</given-names></name><name><surname>Esposito</surname><given-names>G</given-names></name><name><surname>De Lorenzi</surname><given-names>E</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Pries</surname><given-names>M</given-names></name><name><surname>Corlin</surname><given-names>DB</given-names></name><etal/></person-group><article-title>Variants of beta2-microglobulin cleaved at lysine-58 retain the main conformational features of the native protein but are more conformationally heterogeneous and unstable at physiological temperature</article-title><source>FEBS J</source><year>2006</year><volume>273</volume><fpage>2461</fpage><lpage>2474</lpage><pub-id pub-id-type="pmid">16704420</pub-id></element-citation></ref><ref id="b104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corlin</surname><given-names>DB</given-names></name><name><surname>Johnsen</surname><given-names>CK</given-names></name><name><surname>Nissen</surname><given-names>MH</given-names></name><name><surname>Heegaard</surname><given-names>NH</given-names></name></person-group><article-title>A beta2-microglobulin cleavage variant fibrillates at near-physiological pH</article-title><source>Biochem Biophys Res Commun</source><year>2009</year><volume>381</volume><fpage>187</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">19232323</pub-id></element-citation></ref><ref id="b105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>Y</given-names></name><name><surname>Ishiyama</surname><given-names>T</given-names></name><name><surname>Inomata</surname><given-names>A</given-names></name><name><surname>Takeda</surname><given-names>T</given-names></name><name><surname>Senma</surname><given-names>S</given-names></name><name><surname>Okuyama</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name></person-group><article-title>Radiolucent bone cysts and the type of dialysis membrane used in patients undergoing long-term hemodialysis</article-title><source>Nephron</source><year>1992</year><volume>60</volume><fpage>268</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">1565178</pub-id></element-citation></ref><ref id="b106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eakin</surname><given-names>CM</given-names></name><name><surname>Attenello</surname><given-names>FJ</given-names></name><name><surname>Morgan</surname><given-names>CJ</given-names></name><name><surname>Miranker</surname><given-names>AD</given-names></name></person-group><article-title>Oligomeric assembly of native-like precursors precedes amyloid formation by beta2-microglobulin</article-title><source>Biochemistry</source><year>2004</year><volume>43</volume><fpage>7808</fpage><lpage>7815</lpage><pub-id pub-id-type="pmid">15196023</pub-id></element-citation></ref><ref id="b107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eakin</surname><given-names>CM</given-names></name><name><surname>Knight</surname><given-names>JD</given-names></name><name><surname>Morgan</surname><given-names>CJ</given-names></name><name><surname>Gelfand</surname><given-names>MA</given-names></name><name><surname>Miranker</surname><given-names>AD</given-names></name></person-group><article-title>Formation of a copper specific binding site in non-native states of beta2-microglobulin</article-title><source>Biochemistry</source><year>2002</year><volume>41</volume><fpage>10646</fpage><lpage>10656</lpage><pub-id pub-id-type="pmid">12186550</pub-id></element-citation></ref><ref id="b108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendoza</surname><given-names>VL</given-names></name><name><surname>Antwi</surname><given-names>K</given-names></name><name><surname>Baron-Rodriguez</surname><given-names>MA</given-names></name><name><surname>Blanco</surname><given-names>C</given-names></name><name><surname>Vachet</surname><given-names>RW</given-names></name></person-group><article-title>Structure of the preamyloid dimer of beta2-microglobulin from covalent labeling and mass spectrometry</article-title><source>Biochemistry</source><year>2010</year><volume>49</volume><fpage>1522</fpage><lpage>1532</lpage><pub-id pub-id-type="pmid">20088607</pub-id></element-citation></ref><ref id="b109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kameda</surname><given-names>A</given-names></name><name><surname>Morita</surname><given-names>EH</given-names></name><name><surname>Sakurai</surname><given-names>K</given-names></name><name><surname>Naiki</surname><given-names>H</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name></person-group><article-title>NMR-based characterization of a refolding intermediate of beta2-microglobulin labeled using a wheat germ cell-free system</article-title><source>Protein Sci</source><year>2009</year><volume>18</volume><fpage>1592</fpage><lpage>1601</lpage><pub-id pub-id-type="pmid">19606503</pub-id></element-citation></ref><ref id="b110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Booth</surname><given-names>DR</given-names></name><name><surname>Sunde</surname><given-names>M</given-names></name><name><surname>Bellotti</surname><given-names>V</given-names></name><name><surname>Robinson</surname><given-names>CV</given-names></name><name><surname>Hutchinson</surname><given-names>WL</given-names></name><name><surname>Fraser</surname><given-names>PE</given-names></name><name><surname>Hawkins</surname><given-names>PN</given-names></name><name><surname>Dobson</surname><given-names>CM</given-names></name><name><surname>Radford</surname><given-names>SE</given-names></name><name><surname>Blake</surname><given-names>CC</given-names></name><etal/></person-group><article-title>Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis</article-title><source>Nature</source><year>1997</year><volume>385</volume><fpage>787</fpage><lpage>793</lpage><pub-id pub-id-type="pmid">9039909</pub-id></element-citation></ref><ref id="b111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moraitakis</surname><given-names>G</given-names></name><name><surname>Goodfellow</surname><given-names>JM</given-names></name></person-group><article-title>Simulations of human lysozyme: probing the conformations triggering amyloidosis</article-title><source>Biophys J</source><year>2003</year><volume>84</volume><fpage>2149</fpage><lpage>2158</lpage><pub-id pub-id-type="pmid">12668424</pub-id></element-citation></ref><ref id="b112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>JW</given-names></name></person-group><article-title>The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways</article-title><source>Curr Opin Struct Biol</source><year>1998</year><volume>8</volume><fpage>101</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">9519302</pub-id></element-citation></ref><ref id="b113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcon</surname><given-names>G</given-names></name><name><surname>Plakoutsi</surname><given-names>G</given-names></name><name><surname>Canale</surname><given-names>C</given-names></name><name><surname>Relini</surname><given-names>A</given-names></name><name><surname>Taddei</surname><given-names>N</given-names></name><name><surname>Dobson</surname><given-names>CM</given-names></name><name><surname>Ramponi</surname><given-names>G</given-names></name><name><surname>Chiti</surname><given-names>F</given-names></name></person-group><article-title>Amyloid formation from HypF-N under conditions in which the protein is initially in its native state</article-title><source>J Mol Biol</source><year>2005</year><volume>347</volume><fpage>323</fpage><lpage>335</lpage><pub-id pub-id-type="pmid">15740744</pub-id></element-citation></ref><ref id="b114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khare</surname><given-names>SD</given-names></name><name><surname>Dokholyan</surname><given-names>NV</given-names></name></person-group><article-title>Common dynamical signatures of familial amyotrophic lateral sclerosis-associated structurally diverse Cu, Zn superoxide dismutase mutants</article-title><source>Proc Natl Acad Sci USA</source><year>2006</year><volume>103</volume><fpage>3147</fpage><lpage>3152</lpage><pub-id pub-id-type="pmid">16488975</pub-id></element-citation></ref><ref id="b115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiti</surname><given-names>F</given-names></name><name><surname>Dobson</surname><given-names>CM</given-names></name></person-group><article-title>Protein misfolding, functional amyloid, and human disease</article-title><source>Annu Rev Biochem</source><year>2006</year><volume>75</volume><fpage>333</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">16756495</pub-id></element-citation></ref><ref id="b116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiti</surname><given-names>F</given-names></name><name><surname>Dobson</surname><given-names>CM</given-names></name></person-group><article-title>Amyloid formation by globular proteins under native conditions</article-title><source>Nat Chem Biol</source><year>2009</year><volume>5</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">19088715</pub-id></element-citation></ref><ref id="b117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corlin</surname><given-names>DB</given-names></name><name><surname>Sen</surname><given-names>JW</given-names></name><name><surname>Ladefoged</surname><given-names>S</given-names></name><name><surname>Lund</surname><given-names>GB</given-names></name><name><surname>Nissen</surname><given-names>MH</given-names></name><name><surname>Heegaard</surname><given-names>NH</given-names></name></person-group><article-title>Quantification of cleaved beta2-microglobulin in serum from patients undergoing chronic hemodialysis</article-title><source>Clin Chem</source><year>2005</year><volume>51</volume><fpage>1177</fpage><lpage>1184</lpage><pub-id pub-id-type="pmid">15890888</pub-id></element-citation></ref><ref id="b118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heegaard</surname><given-names>NH</given-names></name><name><surname>Jorgensen</surname><given-names>TJ</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Schou</surname><given-names>C</given-names></name><name><surname>Nissen</surname><given-names>MH</given-names></name><name><surname>Trapp</surname><given-names>O</given-names></name></person-group><article-title>Interconverting conformations of variants of the human amyloidogenic protein beta2-microglobulin quantitatively characterized by dynamic capillary electrophoresis and computer simulation</article-title><source>Anal Chem</source><year>2006</year><volume>78</volume><fpage>3667</fpage><lpage>3673</lpage><pub-id pub-id-type="pmid">16737222</pub-id></element-citation></ref><ref id="b119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>K</given-names></name><name><surname>Naiki</surname><given-names>H</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name></person-group><article-title>Mechanism by which the amyloid-like fibrils of a beta2-microglobulin fragment are induced by fluorine-substituted alcohols</article-title><source>J Mol Biol</source><year>2006</year><volume>363</volume><fpage>279</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">16959264</pub-id></element-citation></ref><ref id="b120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellotti</surname><given-names>V</given-names></name><name><surname>Stoppini</surname><given-names>M</given-names></name><name><surname>Mangione</surname><given-names>P</given-names></name><name><surname>Sunde</surname><given-names>M</given-names></name><name><surname>Robinson</surname><given-names>C</given-names></name><name><surname>Asti</surname><given-names>L</given-names></name><name><surname>Brancaccio</surname><given-names>D</given-names></name><name><surname>Ferri</surname><given-names>G</given-names></name></person-group><article-title>Beta2-microglobulin can be refolded into a native state from <italic>ex vivo</italic> amyloid fibrils</article-title><source>Eur J Biochem</source><year>1998</year><volume>258</volume><fpage>61</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">9851692</pub-id></element-citation></ref><ref id="b121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santambrogio</surname><given-names>C</given-names></name><name><surname>Ricagno</surname><given-names>S</given-names></name><name><surname>Colombo</surname><given-names>M</given-names></name><name><surname>Barbiroli</surname><given-names>A</given-names></name><name><surname>Bonomi</surname><given-names>F</given-names></name><name><surname>Bellotti</surname><given-names>V</given-names></name><name><surname>Bolognesi</surname><given-names>M</given-names></name><name><surname>Grandori</surname><given-names>R</given-names></name></person-group><article-title>DE-loop mutations affect beta2-microglobulin stability, oligomerization, and the low-pH unfolded form</article-title><source>Protein Sci</source><year>2010</year><volume>19</volume><fpage>1386</fpage><lpage>1394</lpage><pub-id pub-id-type="pmid">20506535</pub-id></element-citation></ref><ref id="b122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fogolari</surname><given-names>F</given-names></name><name><surname>Corazza</surname><given-names>A</given-names></name><name><surname>Varini</surname><given-names>N</given-names></name><name><surname>Rotter</surname><given-names>M</given-names></name><name><surname>Gumral</surname><given-names>D</given-names></name><name><surname>Codutti</surname><given-names>L</given-names></name><name><surname>Rennella</surname><given-names>E</given-names></name><name><surname>Viglino</surname><given-names>P</given-names></name><name><surname>Bellotti</surname><given-names>V</given-names></name><name><surname>Esposito</surname><given-names>G</given-names></name></person-group><article-title>Molecular dynamics simulation of beta2-microglobulin in denaturing and stabilizing conditions</article-title><source>Proteins</source><year>2011</year><volume>79</volume><fpage>986</fpage><lpage>1001</lpage><pub-id pub-id-type="pmid">21287627</pub-id></element-citation></ref><ref id="b123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monti</surname><given-names>M</given-names></name><name><surname>Amoresano</surname><given-names>A</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Bellotti</surname><given-names>V</given-names></name><name><surname>Pucci</surname><given-names>P</given-names></name></person-group><article-title>Limited proteolysis in the investigation of beta2-microglobulin amyloidogenic and fibrillar states</article-title><source>Biochim Biophys Acta</source><year>2005</year><volume>1753</volume><fpage>44</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">16213198</pub-id></element-citation></ref><ref id="b124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Sawaya</surname><given-names>MR</given-names></name><name><surname>Eisenberg</surname><given-names>D</given-names></name></person-group><article-title>Beta-microglobulin forms three-dimensional domain-swapped amyloid fibrils with disulfide linkages</article-title><source>Nat Struct Mol Biol</source><year>2010</year><volume>18</volume><fpage>49</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">21131979</pub-id></element-citation></ref><ref id="b125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domanska</surname><given-names>K</given-names></name><name><surname>Vanderhaegen</surname><given-names>S</given-names></name><name><surname>Srinivasan</surname><given-names>V</given-names></name><name><surname>Pardon</surname><given-names>E</given-names></name><name><surname>Dupeux</surname><given-names>F</given-names></name><name><surname>Marquez</surname><given-names>JA</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Stoppini</surname><given-names>M</given-names></name><name><surname>Wyns</surname><given-names>L</given-names></name><name><surname>Bellotti</surname><given-names>V</given-names></name><etal/></person-group><article-title>Atomic structure of a nanobody-trapped domain-swapped dimer of an amyloidogenic beta2-microglobulin variant</article-title><source>Proc Natl Acad Sci USA</source><year>2011</year><volume>108</volume><fpage>1314</fpage><lpage>1319</lpage><pub-id pub-id-type="pmid">21220305</pub-id></element-citation></ref><ref id="b126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Dokholyan</surname><given-names>NV</given-names></name></person-group><article-title>A single disulfide bond differentiates aggregation pathways of beta2-microglobulin</article-title><source>J Mol Biol</source><year>2005</year><volume>354</volume><fpage>473</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">16242719</pub-id></element-citation></ref><ref id="b127"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoppini</surname><given-names>M</given-names></name><name><surname>Mangione</surname><given-names>P</given-names></name><name><surname>Monti</surname><given-names>M</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Marchese</surname><given-names>L</given-names></name><name><surname>Arcidiaco</surname><given-names>P</given-names></name><name><surname>Verga</surname><given-names>L</given-names></name><name><surname>Segagni</surname><given-names>S</given-names></name><name><surname>Pucci</surname><given-names>P</given-names></name><name><surname>Merlini</surname><given-names>G</given-names></name><etal/></person-group><article-title>Proteomics of beta2-microglobulin amyloid fibrils</article-title><source>Biochim Biophys Acta</source><year>2005</year><volume>1753</volume><fpage>23</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">16154394</pub-id></element-citation></ref><ref id="b128"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eichner</surname><given-names>T</given-names></name><name><surname>Radford</surname><given-names>SE</given-names></name></person-group><article-title>A diversity of assembly mechanisms for a generic amyloid fold</article-title><source>Mol Cell</source><year>2011</year><comment>in press</comment></element-citation></ref><ref id="b129"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brundin</surname><given-names>P</given-names></name><name><surname>Melki</surname><given-names>R</given-names></name><name><surname>Kopito</surname><given-names>R</given-names></name></person-group><article-title>Prion-like transmission of protein aggregates in neurodegenerative diseases</article-title><source>Nat Rev Mol Cell Biol</source><year>2010</year><volume>11</volume><fpage>301</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">20308987</pub-id></element-citation></ref><ref id="b130"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sindi</surname><given-names>SS</given-names></name><name><surname>Serio</surname><given-names>TR</given-names></name></person-group><article-title>Prion dynamics and the quest for the genetic determinant in protein-only inheritance</article-title><source>Curr Opin Microbiol</source><year>2009</year><volume>12</volume><fpage>623</fpage><lpage>630</lpage><pub-id pub-id-type="pmid">19864176</pub-id></element-citation></ref><ref id="b131"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>G</given-names></name></person-group><article-title>Neurodegeneration. Could they all be prion diseases?</article-title><source>Science</source><year>2009</year><volume>326</volume><fpage>1337</fpage><lpage>1339</lpage><pub-id pub-id-type="pmid">19965731</pub-id></element-citation></ref><ref id="b132"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ladner</surname><given-names>CL</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>DP</given-names></name><name><surname>Platt</surname><given-names>GW</given-names></name><name><surname>Radford</surname><given-names>SE</given-names></name><name><surname>Langen</surname><given-names>R</given-names></name></person-group><article-title>Stacked sets of parallel, in-register beta-strands of beta2-microglobulin in amyloid fibrils revealed by site-directed spin labeling and chemical labeling</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>17137</fpage><lpage>17147</lpage><pub-id pub-id-type="pmid">20335170</pub-id></element-citation></ref><ref id="b133"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debelouchina</surname><given-names>GT</given-names></name><name><surname>Platt</surname><given-names>GW</given-names></name><name><surname>Bayro</surname><given-names>MJ</given-names></name><name><surname>Radford</surname><given-names>SE</given-names></name><name><surname>Griffin</surname><given-names>RG</given-names></name></person-group><article-title>Magic angle spinning NMR analysis of beta2-microglobulin amyloid fibrils in two distinct morphologies</article-title><source>J Am Chem Soc</source><year>2010</year><volume>132</volume><fpage>10414</fpage><lpage>10423</lpage><pub-id pub-id-type="pmid">20662519</pub-id></element-citation></ref><ref id="b134"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debelouchina</surname><given-names>GT</given-names></name><name><surname>Platt</surname><given-names>GW</given-names></name><name><surname>Bayro</surname><given-names>MJ</given-names></name><name><surname>Radford</surname><given-names>SE</given-names></name><name><surname>Griffin</surname><given-names>RG</given-names></name></person-group><article-title>Intermolecular alignment in beta2-microglobulin amyloid fibrils</article-title><source>J Am Chem Soc</source><year>2010</year><volume>132</volume><fpage>17077</fpage><lpage>17079</lpage></element-citation></ref><ref id="b135"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahn</surname><given-names>TR</given-names></name><name><surname>Tennent</surname><given-names>GA</given-names></name><name><surname>Radford</surname><given-names>SE</given-names></name></person-group><article-title>A common beta-sheet architecture underlies <italic>in vitro</italic> and <italic>in vivo</italic> beta2-microglobulin amyloid fibrils</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>17279</fpage><lpage>17286</lpage><pub-id pub-id-type="pmid">18424782</pub-id></element-citation></ref><ref id="b136"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borbulevych</surname><given-names>OY</given-names></name><name><surname>Do</surname><given-names>P</given-names></name><name><surname>Baker</surname><given-names>BM</given-names></name></person-group><article-title>Structures of native and affinity-enhanced WT1 epitopes bound to HLA-A*0201: implications for WT1-based cancer therapeutics</article-title><source>Mol Immunol</source><year>2010</year><volume>47</volume><fpage>2519</fpage><lpage>2524</lpage><pub-id pub-id-type="pmid">20619457</pub-id></element-citation></ref><ref id="b137"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kihara</surname><given-names>M</given-names></name><name><surname>Chatani</surname><given-names>E</given-names></name><name><surname>Iwata</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Matsuura</surname><given-names>T</given-names></name><name><surname>Nakagawa</surname><given-names>A</given-names></name><name><surname>Naiki</surname><given-names>H</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name></person-group><article-title>Conformation of amyloid fibrils of beta2-microglobulin probed by tryptophan mutagenesis</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>31061</fpage><lpage>31069</lpage><pub-id pub-id-type="pmid">16901902</pub-id></element-citation></ref><ref id="b138"><label>138</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hodkinson</surname><given-names>JP</given-names></name><name><surname>Ashcroft</surname><given-names>AE</given-names></name><name><surname>Radford</surname><given-names>SE</given-names></name></person-group><article-title>Protein misfolding and toxicity in dialysis related amyloidosis. Prefibrillar amyloidogenic protein assemblies &#x02013; common cytotoxins underlying degenerative diseases</article-title><year>2011</year><publisher-name>Springer</publisher-name><comment>in press</comment></element-citation></ref><ref id="b139"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>HE</given-names></name><name><surname>Hodgkinson</surname><given-names>JL</given-names></name><name><surname>Jahn</surname><given-names>TR</given-names></name><name><surname>Cohen-Krausz</surname><given-names>S</given-names></name><name><surname>Gosal</surname><given-names>WS</given-names></name><name><surname>Muller</surname><given-names>S</given-names></name><name><surname>Orlova</surname><given-names>EV</given-names></name><name><surname>Radford</surname><given-names>SE</given-names></name><name><surname>Saibil</surname><given-names>HR</given-names></name></person-group><article-title>Globular tetramers of beta2-microglobulin assemble into elaborate amyloid fibrils</article-title><source>J Mol Biol</source><year>2009</year><volume>389</volume><fpage>48</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">19345691</pub-id></element-citation></ref></ref-list><glossary><def-list><title>Abbreviations</title><def-item><term>&#x003b2;<sub>2</sub>m</term><def><p>&#x003b2;<sub>2</sub>-microglobulin</p></def></def-item><def-item><term>DRA</term><def><p>dialysis-related amyloidosis</p></def></def-item><def-item><term>MHC I</term><def><p>major histocompatibility complex class I</p></def></def-item><def-item><term>TFE</term><def><p>2,2,2-trifluoroethanol</p></def></def-item></def-list></glossary></back></article>